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ABSTRACT 
 
Structural and Functional Studies on Human  
Mitochondrial Iron-Sulfur Cluster Biosynthesis. (May 2011) 
Chi-Lin Tsai, B.S., National Chung Hsing University;  
M.S. , National Taiwan University 
Chair of Advisory Committee: Dr. David P. Barondeau 
 
 Iron-sulfur (Fe-S) clusters are critical protein cofactors found in all life forms.  In 
eukaryotes, a well-conserved biosynthetic pathway located in the mitochondria is used to 
assemble Fe-S clusters. Although proteins required for Fe-S cluster biosynthesis have 
been identified, their precise function and mechanism remain elusive. In this study, 
biochemical and biophysical methods are applied to understand molecular details for the 
core components of the human Fe-S cluster biosynthesis: Nfs1, Isd11, Isu2, and frataxin 
(Fxn). Nfs1 is a cysteine desulfurase that converts cysteine into alanine and transfers the 
sulfur to a scaffold protein Isu2 for Fe-S clusters. Fxn depletion is associated with the 
neurodegenerative disease Friedreich’s ataxia (FRDA), and results in a complicated 
phenotype that includes loss of Fe-S clusters.  
The results presented here provide the first in vitro evidence for a stable protein 
complex that exists in at least two forms: an inactive complex with Nfs1, Isd11, and Isu2 
(SDU) components and an active form that also includes Fxn (SDUF). Fxn binding 
dramatically changes the catalytic efficiency (kcat/KM) of Nfs1 from 25 to 10,100 M-1s-1 
 iv 
and enhances the rate of Fe-S cluster biosynthesis 25 fold. Oxidizing conditions diminish 
the levels of both complex formation and Fxn-based activation, whereas Fe2+ further 
stimulates Nfs1 activity. Mutagenesis coupled to enzyme kinetics indicate that one of the 
three conserved cysteines (C104) on Isu2 accepts the sulfane sulfur from Nfs1 and that 
this transfer event likely requires prior binding of Fxn. In vitro interrogation of FRDA 
I154F and W155R and related Fxn variants revealed the binding affinity to SDU 
followed the trend Fxn ~ I154F > W155F > W155A ~ W155R. The Fxn variants also 
have diminished ability to facilitate both sulfur transfer and Fe-S cluster assembly. Fxn 
crystallographic structures reveal specific rearrangements associated with the loss of 
function. Importantly, the weaker binding and lower activity of the W155R variant 
compared to I154F explains the earlier onset and more severe disease progression. 
Finally, these experimental results coupled with computational docking studies suggest a 
model for how human Fxn functions as an allosteric activator and triggers sulfur transfer 
and Fe-S cluster assembly. 
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CHAPTER I 
INTRODUCTION 
 
 Iron-Sulfur clusters (Fe-S) are ubiquitous in all life forms and functions as one of 
the most important protein cofactors in both prokaryotic and eukaryotic cells. Early 
studies on photosynthetic organisms (1) and nitrogen-fixing bacteria (2) revealed 
proteins that were critical for oxidoreduction. These proteins were shown to contain 
complexes of iron and sulfide in the form of two- and four-iron clusters. Several 
different forms of Fe-S clusters have since been discovered in biological systems, 
including [Fe2S2], [Fe3S4], [Fe4S4], [NiFe4S4], [Fe8S7], and [Fe7S9Mo] complexes (3). 
The most common Fe–S clusters found in nature are rhombic, [Fe2S2], or cubic, [Fe4S4], 
clusters that are usually coordinated to cysteine ligands in the proteins (Figure 1-1).  Due 
to their chemical geometry and electronic features, Fe-S clusters play several different 
functions such as electron transfer, coupled proton/electron transfer, substrate 
binding/activation, regulation of gene expression, and sulfur donor (4). Fe-S clusters 
self-assemble in solution from ferrous iron and sulfide and may go through a [Fe2S2] 
intermediate in forming more complex clusters (5). Since ferrous iron and sulfide are 
toxic molecules to the cell, biological systems utilize complex Fe–S cluster assembly 
machinery to sequester and control the reactivity of these molecules.  
 
____________ 
This dissertation follows the style of Biochemistry. 
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Three prokaryotic systems have been discovered that function in the biosynthesis 
of Fe-S cofactors (6, 7). The first system was discovered in 1989 by Dennis Dean’s 
group during studies of the nitrogen-fixing bacteria Azotobacter vinelandii, and is known 
  
 
 
FIGURE 1-1: Various Fe–S clusters found in Fe–S proteins. (A) [Fe2S2] and (B) [Fe4S4] clusters are 
coordinated to cysteine ligands of protein. (C) [Fe8S7] P cluster and (D) [MoFe7S9] FeMo-cofactor are 
found in nitrogenase. (Iron is shown in green, sulfur is yellow, and molybdenum is magenta) 
[Frazzon, J., and Dean, D. R. (2003) Formation of iron-sulfur clusters in bacteria: an emerging field 
in bioinorganic chemistry. Curr. Opin. Chem. Biol. 7, 166-173]. 
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as the nitrogen-fixation (NIF) machinery (8). The NIF pathway is often a specialized 
assembly system that is responsible for assembling the Fe–S clusters for nitrogenase, 
which converts N2 to NH3. A second Fe-S cluster assembly system was discovered in 
1998 by the Dean group and is now known as the iron-sulfur cluster (ISC) pathway (9). 
The ISC machinery is found in a large variety of bacteria and has a general house-
keeping function to generate and insert Fe–S clusters into a majority of the Fe–S proteins 
found in bacterial cells. A third Fe-S assembly system was discovered by the Tokumoto 
 
 
FIGURE 1-2: Eukaryotic machineries for the Fe–S cluster biogenesis and their putative evolutionary 
origin . [Lill, R. (2009) Function and biogenesis of iron-sulphur proteins. Nature 460, 831-838]. 
 4 
group in 2002 and is called the sulfur-mobilization (SUF) machinery (10). The SUF 
system is often found in organisms that also contain the ISC pathway and is thought to 
be activated under iron-limiting or oxidative stress conditions (11). In eukaryotes, the 
primary Fe-S cluster assembly system shares similarity with the bacterial ISC system 
and is located in the mitochondria (Figure 1-2).   
The ISC-like machinery is required for the maturation of most, if not all, Fe–S 
proteins in non-photosynthetic eukaryotes. The ISC pathway contains more than a dozen 
proteins and can be divided into two stages (12-14) (Table 1-1). Early steps involve the 
generation of a transient Fe–S cluster on the scaffold protein Isu2, whereas later steps 
facilitate the transfer of intact Fe–S clusters from Isu2 to target apo-proteins (Figure 1-
3). The sulfur for the biosynthesis of Fe–S clusters is generated by the cysteine 
desulfurase Nfs1, which catalyzes the conversion of cysteine to alanine (15) and 
transfers of the sulfur atom to Isu2. The iron for the biosynthesis of Fe-S clusters may be 
donated by Fxn (16). Electrons required for the reduction of sulfur may be provided by a 
ferredoxin (Fdx), which receives its electrons ultimately from NADH through a 
ferredoxin reductase (FdxR) (17). The monothiol glutaredoxin Grx5 is also important for 
Fe-S biosynthesis, but is not well understood.  Initial studies suggest Grx5 may be 
involved in the regulation of the redox state of Nfs1 and/or scaffold proteins where Fe–S 
clusters initially assemble (18, 19). 
In the later steps of Fe-S cluster biosynthesis, the intact Fe-S cluster is transferred 
from Isu2 to apo target proteins. This process is assisted in humans by the co-chaperone 
Hsc20, the ATP-dependent chaperone Grp75, and the ADP/ATP exchange factor GrpE.  
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Table 1-1: Known Components of Fe–S Cluster Biogenesis in Human Mitochondria 
Name Essential in yeast 
Yeast 
homologs Bacterial homologs Proposed function & protein interactions 
Nfs1 Yes Nfs1 IscS, NifS, SufS Cysteine desulfurase, sulfur donor, Interacts with Isd11, Isu2, Fxn, Nfu 
Isd11 Yes Isd11 – Forms complex with Nfs1, maintains Nfs1 activity, interacts with Nfs1, Fxn 
Isu2 
Yes 
(double 
deletion) 
Isu1/2 IscU, NifU (N-terminal domain) 
Scaffold for cluster assembly 
Interacts with Nfs1, Fxn, GRP75, Hsc20, 
Isa1/2, Nfu 
Fxn No (PET)a Yfh1 CyaY 
Iron donor, iron storage, iron sensor, 
allosteric activator, interacts with Isu2, 
Nfs1, Isd11 
Fdx Yes Yah1 Fdx (middle-domain of NifU?) 
Ferredoxin, reduction of S0 to S2- 
Interacts with FdxR, Nfs1, GRP75 
FdxR Yes Arh1 – Ferredoxin reductase, electron transfer to Fdx from NADH, interacts with Fdx 
GRP75 No, cold sensitivity Ssq1 HscA 
Hsp70 Chaperone, transfer cluster from 
Isu2 to apoprotein, interacts with Hsc20, 
Isu2, Isa1/2 
Hsc20 Yes Jac1 HscB Cochaperone of GRP75, facilitate Isu2 to bind GRP75, interacts with Isu2, GRP75 
GrpE Yes Mge1 GrpE (not required in bacteria) 
ADP/ATP exchange factor on GRP75, 
interacts with GRP75 
Grx5 No Grx5 ? Monothiol glutaredoxin 
Isa1/2 No (PET)a Isa1/2 IscA, SufA, IscANif 
Iron donor, alternate scaffold for 
aconitase-like Fe-S proteins , interacts 
with GRP75, Isu2, Nfs1 
Iba57 ND Iba57 – Forms complex with Isa1/2, maturation of radical-SAM proteins 
Nfu No Nfu1 C-terminal of NifU Unknown? 
 
aPET: no growth on glycerol-containing media 
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The role of Fe-S assembly proteins Isa1/2 and Nfu are less clear. Isa1/2 is required for 
the activation of aconitase-type Fe–S proteins and has been suggested to function as an 
alternate scaffold protein (20) or as an iron donor (21). Nfu1 has also been proposed to 
be an alternate scaffold (22) and in sulfur transfer (23). Human ABCB7 is an ATP-
binding cassette (ABC) transporter of the mitochondrial inner membrane and exports an 
unknown compound that is important for cytosolic and nuclear Fe–S cluster maturation 
and iron homeostasis (24, 25). Fe–S clusters are not only essential for the activities of 
proteins such as aconitase, succinate dehydrogenase, and iron-regulatory protein 1, but 
 
 
FIGURE 1-3: Proposed model for Fe–S cluster assembly in mitochondria [Lill, R. (2009) Function and 
biogenesis of iron-sulphur proteins. Nature 460, 831-838]. 
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are also important for the synthesis of other cofactors including heme (26), biotin (27), 
thiamin (28), and vitamin B12 (29).  
Several human diseases have recently been connected to defects in Fe–S cluster 
biosynthesis. In general, defects for most of the proteins in the Fe–S cluster biosynthesis 
pathway result in iron depletion in the cytosol and an increase in both iron accumulation 
and oxidative stress in the mitochondria. The resulting mitochondrial dysfunction can 
trigger cell apoptosis (30) and can also lead to nuclear genome instability, which is a 
hallmark of human diseases such as cancer (31, 32).  More specifically, mutations in 
Isu2 lead to cardiomyopathy, depletion of Fxn results in Friedreich’s ataxia, and defects 
in Grx5 and ABCB7 result in sideroblastic anemia (14, 33).  
For Isu2, a splice mutation G7044C in the fourth intron of Isu2 was found in 
Swedish patients and thought to be responsible for hereditary myopathy with lactic 
acidosis (34, 35). Isu2 protein levels are significantly reduced in patient muscle cells. 
The depletion of Isu2 causes the dysfunction of Fe–S cluster biosynthesis and 
mitochondrial iron overload in skeletal muscle. Without sufficient Fe–S cluster 
biogenesis, the heme synthetic enzyme ferrochelatase is unstable and is significantly 
degraded in patient muscle (26). A new missense mutation G17E on Isu2 has been found 
recently in two male siblings (36). Patients with G17E mutation demonstrate more 
severe muscle pathology than other Isu2 mutation patients. Clinically, the patients with 
Isu2 mutation have lifelong severe exercise intolerance that begins in childhood.  
 Frataxin defects are associated with the autosomal recessive disease Friedreich’s 
ataxia (FRDA), which is the most common neurodegenerative ataxia (37). FRDA has 
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been estimated to affect 1 in 50,000 Caucasians and a deduced carrier frequency of 1 in 
120 in European populations. FRDA patients typically present symptoms during 
adolescence such as progressive limb and gait ataxia and often die prematurely from 
cardiomyopathy.  There is currently no cure. About 96% of FRDA patients have an 
unstable GAA triplet repeat expansion (66–1700 repeats) in the first intron of the χ25 
gene, whereas about 4% of the patients have point mutations in the χ25 gene. The triplet 
repeat size ranges between 7 and 40 for normal individuals and 66 to >1700 for FRDA 
patients (38, 39). Importantly, larger GAA repeats correlate with lower Fxn expression 
levels and an earlier age of disease onset (40).  The χ25 gene was identified in the FRDA 
locus on chromosome 9q13 and encodes the 210 amino acid protein Fxn (37). Specific 
missense mutations in Fxn will be discussed below. 
 
THE CYSTEINE DESULFURASE COMPLEX NFS1/ISD11 
 Cysteine desulfurases have a critical role in biological sulfur mobilization, 
including Fe–S cluster assembly, thiamine and biotin synthesis, tRNA modifications, 
and molybdopterin biosynthesis (4, 41, 42). The bacterial cysteine desulfurase IscS is a 
homodimer (45 kDa per subunit), which contains one pyridoxal 5’-phosphate (PLP) 
cofactor per subunit. IscS catalyzes the conversion of L-cysteine to L-alanine and 
generates inorganic sulfur (15, 43). During catalysis, a cysteine on a flexible loop attacks 
a substrate–PLP adduct to generate a persulfide species (Figure 1-4). The resulting 
sulfane sulfur can then be transferred in a rate-limiting step to sulfur acceptor proteins 
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such as ThiI, TusA, MoaD/MoeB, or the scaffold protein Isu2 for Fe–S cluster 
biosynthesis (44). Alternately, this persulfide can be reductive cleaved in vitro by 
reducing agents such as DTT to form sulfide ion (45).  
The cysteine desulfurase IscS from E. coli has been extensively studied using 
both structural and functional approaches. In the 2.1 Å IscS crystal structure, the PLP 
cofactor lies at the base of an active site pocket located near the surface of the protein 
  
FIGURE 1-4: Proposed mechanism of cysteine desulfurase by catalyzing cysteine substrate to alanine. 
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(46). The PLP cofactor forms an internal aldimine Schiff base with K206 and interacts 
with a number of polar and non-polar residues. H104 sits directly above the pyridine ring 
of PLP and functions as an acid–base catalyst (Figure 1-5A). Remarkably, an estimated 
distance of greater than 17 Å between the crucial C328 residue and PLP cofactor implies
  
 
 
 
a large conformational movement is required for the nucleophilic attack by C328 on the 
substrate cysteine bound to the PLP cofactor (Figure 1-5B). 
     (A)            (B) 
 
 
FIGURE 1-5: (A) The active site pocket of cysteine desulfurase IscS (PDB: 1P3W). (B) The distance 
between catalytic C328 residue and PLP cofactor [Cupp-Vickery, J., Urbina, H. D., and Vickery, L. 
(2003) Crystal structure of IscS, a cysteine desulfurase from Escherichia coli. J. Mol. Biol. 330, 1049-
1059]. 
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 The human cysteine desulfurase Nfs1 exists in two distinct isoforms: a 47 kDa 
protein (Δ1-55 a.a.) that is located in the mitochondria, and a 44 kDa (Δ1-60 a.a.) form 
that is found in the cytosol and nucleus (47). There currently is no structural information 
for eukaryotic cysteine desulfurases. However, the crystal structure of E. coli IscS might 
provide a reasonable model for human Nfs1, as these proteins share 60% sequence 
identity (46).  Isolated human Nfs1 (Δ1-55 a.a.) is a 94 kDa homodimeric protein that is 
reported to be inactive and have a tendency to aggregate and precipitate (48).  
In 2006, the 11 kDa protein Isd11 was found to have an essential role in Fe–S 
cluster biosynthesis in mitochondria (49). A C-terminal His-tag was attached to Isd11 
allowing pull-down assays of crude cell extracts and the identification of its protein 
partner, Nfs1 (50). Homologues of the Isd11 gene have been detected in plant, fungi, and 
animal genomes, but not in prokaryotes. This suggests that Isd11 is a unique eukaryotic 
protein that arose after the process of endosymbiosis that generated eukaryotic 
mitochondria (51). Importantly, Isd11 was found to stabilize Nfs1 by forming a tight 
(~100 nM) complex, and this complex was shown to be catalytically active (48). 
Separate overexpression of Nfs1 and Isd11 in E. coli cells resulted in an inactive 
cysteine desulfurase prone to aggregation and inclusion body formation, respectively. In 
contrast, coexpression of Nfs1 and Isd11 in E. coli cells produced a soluble, well-
behaved Nfs1/Isd11 complex in reasonable (~3 mg per liter of cell) yield (48, 52). This 
suggests Nfs1 and Isd11 have to be in complex to maintain their normal function. From 
the E. coli IscS crystal structure (Figure 1-5A), PLP is located near the dimer interface. 
Perhaps, Isd11 stabilizes the folding of Nfs1 to properly bind the PLP cofactor. Isd11 
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contains an unusually large number of positively charged amino acids (6 Lys and 14 Arg 
residues per 91 amino acids) and an estimated pI of about 10.7 
(http://www.scripps.edu/~cdputnam/protcalc.html). Although the structure of Isd11 is 
not known, we hypothesize that the positively charged Isd11 stabilizes the negatively 
charged Nfs1 dimer interface through electrostatic complementation.  
 
THE ISU SCAFFOLD PROTEIN  
IscU is small ~14 kDa protein that functions as the catalyst for Fe-S cluster 
biosynthesis by combining iron, sulfur, and electrons into Fe-S clusters and then 
transferring these clusters to apo targets. To achieve this biological function, IscU must 
not only conserve its active site for cluster assembly but also maintain its protein-protein 
interactions with partner proteins frataxin (16), cysteine desulfurase (44), and 
chaperones (53, 54). As a consequence of these functional requirements, IscU is one of 
the more highly conserved proteins in evolution based on sequence identity (55). For 
example, E. coli IscU and S. cerevisiae Isu1 share 72% and 55% sequence identity with 
human Isu2 (Figure 1.6). 
The human Isu gene encodes two forms of the protein by alternative splicing. 
The Isu1 (15 kDa) form is located in the cytosol, whereas the Isu2 (14 kDa) form is 
imported into mitochondria (56). Human Isu2 acts as a scaffold protein to assemble 
[Fe2S2] clusters and possibly, [Fe4S4] clusters. Isu2 contains three conserved cysteine 
residues (C35, C61, and C104) that could function as Fe–S cluster ligands (Figure 1-6). 
The fourth ligand is unclear and has been suggested to be H103 (57, 58), the 
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nonconserved C96 (59), and cysteine residues from another Isu2 molecule in a dimeric 
arrangement (60). 
 
 
 
 
 
 In 2003, Bertini et al. reported the structural characterization of IscU from T. 
maritima by NMR. IscU displays a dynamic equilibrium between two or more distinct 
conformations, possibly existing in a molten globular state (61). In 2004, the similar 
studies have been suggested that IscU exists in multiple discrete conformers (62). In 
2008, Shimomura et al. determined the crystal structure of the asymmetric trimeric 
structure of IscU at 2.3 Å resolution from the hyperthermophilic bacterium Aquifex 
 
FIGURE 1-6: Sequence alignment of human Isu2 with other indicated species. 
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aeolicus (58). A [Fe2S2] cluster was bound to residues C36, C63, H106 and C107 in one 
of the three subunits of the trimer. The N-terminal regions of the different subunits 
exhibited significantly different conformations and were positioned at the protein-protein 
interfaces, apparently to stabilize the trimeric unit (Figure 1-7). The two subunits that do 
not have a [Fe2S2] cluster have disulfide bond linkage between C107 (equivalent to 
human C104) and C36 (equivalent to human C35) and between C107 and C63 
(equivalent to human C61). The C-terminal regions of these two subunits near C107 
undergo a substantial conformational change that result in a helix to coil conversion. 
  
 
 
 
(A)           (B) 
 
 
FIGURE 1-7: Crystal structure of A. aeolicus IscU trimer (PDB: 2Z7E) (B) Alignment of three IscU 
subunits. C107 was labeled for subunit colored magenta. 
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These residues include a LPPVK motif, which is known to become unfolded and interact 
with the chaperone HscA (equivalent of human Hsc20) (63).  
 
THE ROLE OF FRATAXIN AND FRDA MUTANTS 
 Frataxin (Fxn) has been intensively studied, yet its biological role remains 
undefined and controversial. In prokaryotes, Fxn is not part of the ISC operon and 
appears to be dispensable for Fe-S cluster biosynthesis. In eukaryotes, Fxn is a 
mitochondrial protein and its depletion leads to mitochondrial iron accumulation, 
oxidative stress, and defects in Fe–S cluster and heme biosynthesis (64).  
Once Fxn is incorporated into the mitochondria it undergoes a two-step 
maturation process. The full-length Fxn (1-210 a.a.), which contains a mitochondrial 
targeting sequence, is cleaved by the mitochondrial processing peptidase (MPP) and 
results in a protein that contains amino acids 56-210 (Fxn56-210). The Fxn56-210 is further 
cleaved by MPP to a protein with amino acids 81-210 (Fxn81-210), referred to as mature 
Fxn. When the normal maturation process of Fxn is impaired, Fxn56-210 and Fxn78-210 (78-
210 a.a.) are generated (65). Most researchers agree that the mature form of Fxn (Fxn81-
210) is physiologically relevant, but the biological roles of the Fxn56-210 and m78-Fxn 
forms are still hotly debated.  
Recently, the Isaya group reported the Fxn56-210 form can oligomerize into a 
greater than 1 MDa particle that can stimulate Fe–S cluster formation on Isu2 in the 
presence of Nfs1 and Isd11, and that both the Fxn81-210 and Fxn56-210 forms are relevant 
to FRDA pathophysiology (66). Interestingly, EM and EXAFS studies suggest the Fxn56-
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210 oligomer has an overall structure similar to the iron-storage protein ferritin (67), and 
that the cavity inside the oligomer can store more than 2000 iron in the form of 
ferrihydrite (68-70). The in vitro assembly of the oligomer by bacterial and yeast Fxn 
can be initiated by the addition of ferrous iron in the presence of oxygen (71, 72).  In 
contrast, human Fxn56-210 does not oligomerize under similar in vitro conditions.  The 
oligomeric form for human Fxn can be generated by some unknown factor present 
during recombinant overexpression (73). Once the N-terminus is cleaved and the mature 
form of Fxn (Fxn81-210) is generated the oligomeric form is no longer observed leading to 
storage is not a critical function of Fxn (74). More evidence is required to establish the 
  
 
 
 
FIGURE 1-8: Proposed functions for frataxin in mitochondria iron metabolism [Lane, D. J. R., and 
Richardson, D. R. (2010) Frataxin, a molecule of mystery: trading stability for function in its iron-
binding site. Biochem. J. 426, e1-3]. 
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the suggestion that the non-conserved N-terminal region (56–80 a.a.) is important for 
Fxn oligomer assembly (73). Aloria et al. generated an oligomerization-deficient strain 
in yeast that did not show any growth defects or phenotype, which suggests that iron iron 
storage role of Fxn oligomer (Figure 1-8A). 
Several functions have been proposed for Fxn other than iron storage (Figure 1-
8) (75). The susceptibility of Fxn-deficient mitochondria to oxidative stress has lead to 
the proposal that Fxn plays a direct role in oxidative stress control (Figure 1-8B). 
Oligomeric Fxn is proposed to facilitate an iron-mediated ferroxidase reaction that may 
remove ferrous iron before it can generate toxic reactive oxygen species through Fenton 
chemistry (76). Fxn is also proposed to function as an iron chaperone (Figure 1-8C) and 
binds iron through its unique acidic patch (13 carboxylate residues) on its α1 helix 
  
 
 
 
FIGURE 1-9: Ribbon representation of human frataxin structure. Aspartate and glutamate residues on 
helix 1 (α1) were shown in stick. 
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(Figure1-9), and then deliver iron for biosynthetic pathways for Fe-S clusters and heme 
cofactors (77, 78). A related proposal suggests Fxn functions as a metabolic switch 
(Figure 1-8D) to control iron flux between Fe-S and heme pathways (79). Finally, an 
iron sensor role (Figure 1-8E) was recently proposed based on studies of the E. coli Fxn 
homologue CyaY. Results from the Pastore group reveal that CyaY inhibits the rate of 
Fe-S cluster biosynthesis under high iron conditions, suggesting a negative regulator role 
(80). All of these functions are closely connected to Fe–S cluster and heme biosynthesis 
or, more specifically, to iron. Indeed, knockout of the Fxn gene alters the regulation of 
cellular iron homeostasis. Recently, Rouault’s group suggested Fxn expression can be 
regulated by iron (81) or transcription factors SRF and TFAP2 (82). Fibroblast and 
lymphoblast cells treated with iron chelator, desferal, have decreased Fxn mRNA and 
protein expression levels (81). Over-expression of either SRF or TFAP2 significantly 
increased Fxn mRNA and protein levels in HEK293 cells (82). Toward to the end, the 
exact function of Fxn is still a puzzle, but most researchers believe Fxn is directly related 
to Fe–S cluster biosynthesis and acts as an iron donor. 
 Fxn has been shown to be associated with the neurodegenerative disease 
Friedreich ataxia (FRDA) (37). A small fraction of FRDA patients have an expanded 
GAA repeat on one allele and a point mutation on the other allele (83).  In these cases, 
the Fxn protein levels do not necessarily correspond to the age of onset (39, 84). About 
15 point mutations have been found in FRDA patients (39) (Figure 1-10A), mostly in 
exons 3-5a. A comparison of FRDA mutants with the Fxn conserved residues suggests
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residues D122, Q148, W155, L156, W173, and L186 are important for Fxn protein 
function. Mapping these mutations onto the Fxn structure revealed that most are located 
in the conserved β-sheet region (Figure 1-10B). Recent chemical denaturation studies 
indicate Fxn mutations decrease the protein stability in the order of wild-type > W155R 
> I154F > D122Y > G130V (85-87). W155 is the only absolute conserved residue in Fxn 
among all the organisms. Mutation of I154 and W155 residues to alanine inhibit cell 
growth in yeast cell (88). The mutation of W155 to alanine strongly decreases the 
interaction with yeast Isu1 (homologous to human Isu2) based on pull-down experiments 
(88). Gomes’s group also suggest W155 may be a functional hotspot in frataxin for 
oxidative stress protection based on chemical modification experiments (86). Together 
these results lead to the conclusion that the conserved β-sheet residues, particularly 
W155, are important for protein stability and function. Unfortunately, little is known 
about how these residues affect protein function. Therefore, structural studies coupled to 
 
 
FIGURE 1-10: (A) The distribution of FRDA point mutations (magenta) on human Fxn structure. (B) The 
distribution of conserved residues (goldenrod) on human Fxn structure. 
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the development of functional assays are required to understand the effects of Fxn 
FRDA mutants on Fe–S cluster biosynthesis. 
 
ISCU-ISCS INTERACTIONS AND SULFUR TRANSFER  
In 2010, a crystal structure of the IscS–IscU complex from E. coli was 
determined to 3.0 Å resolution (Figure 1-11A) (44). This was the first structural snapshot 
that revealed molecular details for the protein complex containing the cysteine 
desulfurase and scaffold protein for Fe-S cluster biosynthesis. During IscS cysteine 
desulfurase (homologous to human Nfs1) catalysis, C328 on a mobile loop attacks the 
substrate-PLP adduct to cleave the C-S bond of the L-cysteine substrate and generate a 
persulfide species on C328. In the crystal structure of the IscS-IscU complex, the 
persulfide cysteine loop is not visible in the electron density maps due to conformational 
disorder. The distance between the expected position of the C328 of IscS and the 
conserved cysteines on IscU has been estimated to be between 12 and 18 Å (Figure 1-
11B). Previously, the Vickery group estimated the distance between C328 and the PLP 
cofactor to be greater than 17 Å (46). Together these results suggest C328 on IscS is able 
to sample a distance of ~30 Å and transfer the sulfur from the cysteine-PLP adduct to a 
cysteine residue on IscU (homologous to human Isu2). It is unclear if this sulfur transfer 
event from IscS C328 is to a specific cysteine residue on IscU. 
The sulfur transfer mechanism from IscS to IscU remains elusive. In 2002, Kato 
et al. found that C63 of E. coli IscU stimulates the cysteine desulfurase activity of IscS
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(89).  In addition, C63 of IscU forms a disulfide bridge with C328 of IscS in a covalent 
IscU-IscS complex (89). In 2005, Smith et al. showed that a heterodisulfide is formed in 
the A. vinelandii system between IscS and C37 of IscU, and that IscS can transfer sulfur 
to each of the three cysteine residues (90). Smith et al. questioned the studies on the 
heterodisulfide complex using E. coli IscU and IscS because the IscU contained a C-
terminal His-tag and the experiments were not performed under anaerobic conditions. 
The equivalent types of sulfur transfer experiments have not been performed on a 
eukaryotic system. 
        (A)          (B) 
 
 
FIGURE 1-11: Crystal structure of E. coli IscS-IscU complex (PDB: 3LVL). (A) IscS-IscU forms a 
heterodimer complex. (B) C328 on the loop of IscS structure was missing. The estimate distances from 
loop to cysteine residues on IscU were labeled. 
 
 22 
PROPOSED MECHANISMS FOR FE-S CLUSTER ASSEMBLY 
Two possible Fe–S cluster assembly mechanisms that differ in the order of Fe 
and S incorporation have been proposed for the SUF system (91-93). These two 
proposals are referred to as the “iron-first” and “sulfur-first” mechanisms (Figure 1-12). 
In the iron-first mechanism, two Fe2+ atoms are ligated by two conserved cysteine 
residues in each subunit of the scaffold protein SufA (homologous to human Isu2) 
dimer, followed by sulfane sulfur (S0) transfer from a cysteine desulfurase (Figure 1-
12A). The two sulfane sulfurs were reduced a total of four electrons for incorporation 
into the Fe-S cluster.  Two of the electrons come from the ferrous iron atoms, and the 
other two electrons are derived from either an external electron source (ferredoxin or 
DTT) or a redox active dithiol group from one of the conserved cysteines (Figure 1-12A) 
to generate the sulfide-bridged diferric species. In the sulfur-first mechanism, a 
persulfidic sulfur was transferred from a cysteine desulfurase to one of the cysteines on 
each subunit of the SufA dimer, followed by the incorporation of two Fe2+ that ligated 
both cysteine and persulfide species (Figure 1-12B). The sulfide-bridged Fe2+ species 
were then reduced by two ferrous iron and two external electrons to generate the [Fe2S2] 
cluster. Evidence against the Fe-first mechanism is the observation that the scaffold 
protein SufA only weakly binds ferrous iron to residues other than the conserved 
cysteines (91). There is currently no evidence for ferrous iron binding to E. coli IscU and 
A. vinelandii IscU (94, 95). In contrast, Thermotoga maritima IscU binds both ferrous 
and ferric iron with a binding constant in the µM range (96). In the sulfur-first model, it
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(A) 
 
(B) 
 
 
FIGURE 1-12: Proposed Fe–S cluster assembly mechanism. (A) “Fe” first model (B) “S” first model 
[Fontecave, M., Choudens, S. O. d., Py, B., and Barras, F. (2005) Mechanisms of iron-sulfur cluster assembly: 
the SUF machinery. J. Biol. Inorg. Chem. 10, 713-721]. 
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was shown that persulfide- or polysulfide-bound IscU can be obtained by incubating 
with IscS and cysteine (94, 97). However, the persulfide or polysulfide-bound IscU is 
not viable to forming Fe–S cluster upon incubation with iron (94). The mechanism of 
Fe-S cluster assembly has yet to be resolved and requires further investigation. 
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CHAPTER II 
HUMAN FRATAXIN IS AN ALLOSTERIC SWITCH THAT ACTIVATES THE 
FE-S CLUSTER BIOSYNTHETIC COMPLEX* 
 
INTRODUCTION 
Iron-sulfur (Fe-S) clusters are essential cofactors that are required for 
biochemical reactions and processes in all life forms. In vitro, iron and sulfide can be 
used to chemically synthesize Fe-S clusters or activate apo Fe-S proteins (4, 98). In vivo, 
Fe-S clusters are synthesized by biosynthetic pathways that are required to circumvent 
the toxicity and indiscriminant reactivity of “free” iron and sulfide. Fe-S clusters are 
synthesized in prokaryotes using the nitrogen fixation (NIF), iron-sulfur cluster assembly 
(ISC), and mobilization of sulfur (SUF) pathways (7). In eukaryotes, the biosynthesis of 
Fe-S clusters occurs in the matrix space of the mitochondria and includes at least a dozen 
proteins (13, 33). Defects in the human Fe-S cluster biosynthesis pathway are associated 
with cardiomyopathy, neurodegenerative ataxia, and contribute to genomic instability, 
the development of cancer, and aging (13, 31, 32).   
 Many of the required proteins for Fe-S cluster biosynthesis have been identified 
and their general biochemical function elucidated. Human Isu2 (homolog of the bacterial
  
 
____________ 
*This chapter is reprinted with permission from “Human Frataxin is an Allosteric Switch 
That Activates the Fe-S Cluster Biosynthetic Complex” by Tsai, C.-L., Barondeau, D.P., 
2010. Biochemistry, 49, 9132-9139, Copyright [2010] by American Chemical Society. 
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IscU) is a 14 kDa monomer (59) that provides a scaffold for building [Fe2S2] and, 
possibly, [Fe4S4] clusters. Clusters are synthesized on Isu2 through interactions with 
proteins that mediate sulfur, iron, and electron transfer. Sulfur atoms are provided by the 
94 kDa homodimeric cysteine desulfurase Nfs1, which catalyzes the PLP-dependent 
breakdown of cysteine to alanine (15, 43). During Nfs1 catalysis, a cysteine on a flexible 
loop attacks a substrate-PLP adduct to generate a persulfide species. The resulting 
sulfane sulfur can then be transferred in a rate-limiting step to the scaffold protein for 
Fe-S biosynthesis, or, in vitro, can be reductively cleaved by redox agents to form 
sulfide ion (15, 45). Iron atoms have been proposed to be donated by both frataxin (Fxn) 
(16, 99, 100) and IscA (21). Electrons may be provided by a ferredoxin (17, 101). 
Finally, chaperone proteins interact with Isu and assist in delivering intact Fe-S clusters 
to their apo targets (53).  ATP and GTP are also required during some stage of Fe-S 
cluster biogenesis (102). 
 The role of Fxn in this Fe-S cluster assembly process remains elusive. In vivo 
studies support a role for the 14 kDa monomeric Fxn in Fe-S cluster assembly (103, 
104), possibly as an iron chaperone. An iron detoxification and storage role has also 
been proposed (71, 105) and refuted (74, 106). Recently, Pastore and coworkers 
provided evidence that the Escherichia coli Fxn homolog functions as a negative 
regulator for Fe-S cluster assembly (80). Such a function for eukaryotic Fxn is difficult 
to reconcile with genetic and biochemical data, which suggest Fxn facilitates rather than 
inhibits Fe-S cluster biosynthesis (16, 103, 104, 107, 108). Further kinetic experiments 
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that address the effect of human frataxin on Fe-S cluster biosynthesis are required to 
resolve this issue.  
 A network of protein-protein interactions appears to be critical for Fe-S cluster 
biosynthesis (13, 109). Fxn, Isu, and Nfs1 physically interact in pull-down experiments 
using yeast (108) and human (110) mitochondrial extracts. Iron-dependent Fxn-Isu 
interactions are further supported by genetic studies in yeast (111) and biophysical 
experiments on recombinant human proteins (16). Isu-Nfs1 interactions are defined by a 
crystal structure of the homologous E. coli IscU-IscS complex (44). In eukaryotes, an 
additional protein, Isd11, is also known to complex with Nfs1 and is vital for Nfs1 
function (49, 50, 112). Deletion of genes encoding Nfs1, Isd11, Isu1, or Fxn in 
Saccharomyces cerevisiae produces similar phenotypes that include defects in Fe-S 
cluster proteins (50, 113). These data hint at a multiprotein complex that functions as a 
Fe-S cluster assembly machine. Here in vitro evidence is presented that the foundation 
for the human Fe-S cluster assembly machine is made up of a Nfs1, Isd11, Isu2, and Fxn 
protein complex. In addition, kinetic data is provided that supports a role for human Fxn 
as an allosteric switch that activates this complex for Fe-S cluster biosynthesis.  
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EXPERIMENTAL PROCEDURES 
 Protein Expression and Purification. Plasmids containing human Nfs1 (Δ1-55) 
and Isd11 (pZM4) were generously provided by S. Leimkühler (48). The Nfs1 and Isd11 
plasmids were transformed into E. coli strain BL21(DE3) for coexpression. Cells were 
grown at 37 oC until they reached an OD600 of 0.6; the temperature was decreased to 16 
oC, and protein expression was induced with 0.1 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG). Cells were harvested 16 h later by centrifugation in 3,500 
g at 4 oC for 20 min and transferred to a temperature-controlled (10−15 oC) anaerobic 
glovebox (mBraun). Cells were resuspended in 100 mL of Buffer A [50 mM Tris (pH 
8.0)] with 500 mM NaCl, 5 mM imidazole, and 100 µM pyridoxal 5’-phosphate (PLP) 
and ruptured by sonication (Branson sonifier 450, 30 sec ×9, 3 min off). The cell lysate 
was transferred into centrifuge bottles with O-ring gaskets and centrifuged in 18,000 g at 
4 oC for 20 min. The soluble protein was loaded onto a Ni-NTA column (16/13, 
GBiosciences) and eluted with a linear gradient from 5 to 250 mM imidazole. Yellow 
fractions were concentrated by Amicon in the glovebox, combined with 100 µM PLP, 5 
mM dithiothreitol (DTT), and 2 mM EDTA, and loaded onto a Sephacryl S300 column 
(26/60, GE) equilibrated in buffer A with 250 mM NaCl. Fractions containing Nfs1 (47 
kDa) and Isd11 (11 kDa) were > 95% pure as determined by 14% SDS-PAGE. Protein 
concentrations were estimated by the Bradford assay (114) or using an extinction 
coefficient of 42670 M-1cm-1 at 280 nm (115). The yield of Nfs1 and Isd11 was 3 mg/L 
of cells. Nfs1/Isd11 protein complex (SD) was then aliquoted and frozen in liquid 
nitrogen and stored at – 80 oC freezer until use. 
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The human Isu2 (Δ1-35) and Fxn (Δ1-55) genes were codon-optimized for E. 
coli, synthezied by IDT, and subcloned into pET11a vectors. The resulting plasmids 
were transformed into E. coli BL21(DE3) cells, which were grown at 37 oC. Protein 
expression was induced at an OD600 of 0.6 with 0.5 mM IPTG. Cells were harvested 5 h 
later and sonicated (45 sec × 6, 3 min off on ice) in 100 mL of buffer B [50 mM Tris (pH 
7.5)]. The cell lysate was centrifuged in 18,000 g at 4 oC for 20 min. 
For Isu2 purification, the soluble protein was applied to an anion exchange 
column (26/22, POROS 50HQ, Applied Biosystems), and the flow-through was 
collected (Isu2 does not bind, pI ≈ 8.9) and loaded onto a cation exchange column 
(16/14, POROS 50HS, Applied Biosystems). Isu2 was eluted with a linear gradient from 
0 to 400 mM NaCl in buffer B. Isu2 fractions (14 kDa, ran around 17 kDa on 14% 
SDS−PAGE) were concentrated by Centricon or Amicon and further purified with a 
Sephacryl S300 column (26/60) equilibrated in buffer C (50 mM HEPES, pH 7.5, 150 
mM NaCl). An extinction coefficient of 8250 M-1cm-1 at 280 nm (115) was used to 
estimate the protein concentration. This procedure yielded 4 mg of > 95% pure Isu2/L of 
cells. Isu2 protein was then aliquoted and frozen in liquid nitrogen and stored at – 80 oC 
freezer until use. 
For Fxn purification, cells were resuspended in 100 mL of buffer B and ruptured 
by sonication (45 sec × 6, 3 min off) on ice. The cell lysate was centrifuged in 18,000 g 
at 4 oC for 20 min. The soluble fraction was loaded onto an anion exchange column 
(26/22, POROS 50HQ) and eluted with a linear gradient from 0 to 800 mM NaCl in 
buffer B. The monomeric Fxn fractions (monitored by 14% SDS-PAGE) were collected 
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and further purified on a S300 gel filtration column equilibrated in buffer C. The 
fractions containing full-length (residues 56-210, 17 kDa) and truncated (residues 82-
210, 14 kDa) Fxn were collected and further purified by anion exchange column (26/22) 
using a linear gradient from 120 to 250 mM NaCl in buffer B. Full-length and truncated 
Fxn were collected separately and confirmed by N-terminal sequencing. Truncated Fxn 
was used for all experiments (unless stated otherwise). An extinction coefficient of 
26030 M-1cm-1 at 280 nm (115) was used to estimate the protein concentration. This 
procedure yielded 6 mg of > 95% pure truncated Fxn/L of cells. 
Cysteine Desulfurase Activity Measurements. Sulfide production for SD was 
measured using slight modification to a methylene blue assay described by Leimkühler 
and co-workers (48, 116). Assay mixtures in a total volume of 0.8 mL contained 1 µM 
SD, 10 µM PLP, 2 mM DTT, 50 mM Tris (pH 8.0), and 250 mM NaCl. The reactions 
were initiated by addition of L-cysteine (0.1−1.0 mM) and the mixtures incubated at 37 
oC. Sulfide production was linear for the first 30 min, and an incubation time of 10 min 
was chosen to generate sufficient product for straightforward detection. Assays were 
quenched by addition of 100 µM of 20 mM N,N-dimethyl-p-phenylenediamine in 7.2 N 
HCl and 100 µL of 30 mM FeCl3 in 1.2 N HCl. After being incubated for 20 min to 
allow for methylene blue synthesis, the samples were centrifuged at 12,000 g for 5 min 
at room temperature, and the absorbance at 670 nm was converted to a sulfide 
concentration using a standard curve (0−70 µM Na2S). 
Similarly, cysteine desulfurase activities were measured for SD after 30 min 
anaerobic incubation with 3 equiv. of Isu2 or Fxn. In a separate experiment, 3 equiv. of 
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Isu2 and Fxn were incubated with SD for 30 min prior to initiation of the reaction with 
L-cysteine (2.5−200 µM). Michaellis−Menten kinetics for the cysteine desulfurase 
reaction were also examined for the protein components in the presence of 10 equiv of 
Fe(NH4)2(SO4)2. All the reactions with Fe(NH4)2(SO4)2 were sealed in round-bottom 
flask to maintain their anaerobic condition. Reaction rates as a function of cysteine 
concentration were fit to the Michaelis–Menten equation using KaleidaGraph (Synergy 
Software). 
The cysteine desulfurase activity was also determined at a “physiological” (0.1 
mM) cysteine concentration with 1 µM SD alone, and with 3 equiv of Isu2 and/or Fxn. 
For the Fe titration, the proteins were diluted by a factor of 2 and 0–5 µM 
Fe(NH4)2(SO4)2 was added. To assess if other metal ions also stimulated cysteine 
desulfurase activity, the assay of SD with 3 equiv of both Isu2 and Fxn was repeated in 
the presence of 10 equiv of MnCl2, FeCl3, CoSO4, NiCl2, CuSO4, Zn(OAc)2, Ca(OAc)2, 
or MgCl2. 
Fe–S Cluster Formation Assay. Assay mixtures in 0.25 mL contained 8 µM SD, 
24 µM Isu2, 100 µM Fe(NH4)2(SO4)2, 3 mM DTT, and 0–16 µM Fxn in 50 mM Tris (pH 
7.4) with 250 mM NaCl. The assay mixture was incubated in an anaerobic glovebox for 
30 min before the reaction was initiated with 0.1 mM L-cysteine. Fe–S cluster formation 
was monitored at 456 nm for 90 min. Units are defined as the amount of Isu2 required to 
produce 1 µmol of Fe–S cluster per minute at 25 oC. An extinction coefficient of 5.8 
mM-1cm-1 was used for [Fe2S2] cluster absorption (117). The rate of Fe–S cluster 
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formation was fit to first-order kinetics by using Agilent UV-Visible ChemStation 
Software. 
Protein Complex Determination. Assays included 40 µM SD, 120 µM Isu2, 120 
µM Fxn, 10 mM DTT, 10 mM EDTA, 0.8 mM Fe(NH4)2(SO4)2, 100 mM HEPES (pH 
7.5), and 50 mM NaCl. Samples were incubated for 30 min in an anaerobic glovebox 
and evaluated for protein complex formation using blue native gels (118) that contained 
6.5% separating and 5% stacking layers.  The gel running buffer was chilled. Titration 
experiments with Fxn and Isu2 were performed using the same procedure except the 
titrant concentration was varied from 5 to 120 µM. The amount of protein on the native 
gel was estimated by densitometry; gels were scanned with a Typhoon Trio Imager and 
analyzed with ImageQuant Software (Protein Chemistry Lab, Department of 
Biochemistry and Biophysics, TAMU). The slower migration band was cut out of the 
native gel and dehydrated with 66% acetonitrile in 25 mM ammonium bicarbonate 
(ABC) (pH 8). The protein was extracted by incubation with 0.1% SDS and 10 mM 
ABC (pH 8) for 30 min at room temperature and mixed with an equal volume of 66% 
acetonitrile and 25 mM ABC (pH 8). The solution was centrifuged in 12,000g for 5 min. 
The supernatant was concentrated with a speed-vac to about 12 µL, and the protein was 
analyzed by 14% SDS-PAGE. 
Protein Complex Isolation. SD was incubated with 3 equiv of Isu2 and Fxn, 2 
equiv of PLP, 5 mM Tris(2-carboxyethyl)phosphine (TECP) or DTT, and 50 mM Tris 
(pH 7.4) with 50 mM NaCl buffer for 30 min in an anaerobic glovebox. The Nfs1, Isd11, 
and Isu2 complex (SDU) and the Nfs1, Isd11, Isu2, and Fxn complex (SDUF) were 
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loaded onto a Sephadex S200 gel filtration column (16/30, GE) and compared to 
molecular weight standards (Bio-Rad) included bovine thyroglobulin (670 kDa), bovine 
γ–globulin (158 kDa), chicken ovalbumin (44 kDa), horse myoglobin (17 kDa), and 
vitamin B12 (1.4 kDa). SDU and SDUF were also further purified on a cation exchange 
column and eluted with a linear gradient from 150 to 1000 mM NaCl in buffer B. Protein 
complexes were confirmed by 14% SDS-PAGE. 
 
RESULTS 
Isu2 and Frataxin Stimulate Nfs1 and Isd11 Cysteine Desulfurase Activity. 
Human recombinant Fxn and Isu2 were assayed for their ability to alter the kinetics of 
the cysteine desulfurase for Fe–S cluster assembly biosynthesis. In this assay, substrate 
cysteine was converted to alanine and the resulting persulfide intermediate was reduced 
with DTT and detected as sulfide. In the absence of additional proteins, purified human 
recombinant SD exhibited Michaelis–Menten kinetics (Figure 2-1) for sulfide production 
with a Michaelis constant (KM) of 0.34 mM for cysteine and a kcat of 1.9 min-1 (Table 2-
1). The resulting catalytic efficiency (kcat/KM) of 93 M-1s-1 for recombinant human SD 
was nearly identical to a previously reported value (48) of 96 M-1s-1. The kinetics 
parameter kcat and KM were not significantly changed upon addition of Fxn to SD. In 
contrast, the kcat was lowered by a factor of 2 and the KM nearly doubled upon addition of 
Isu2 to SD (Table 2-1). 
Both the kcat and the KM were dramatically altered by the addition of Fxn to SD in
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the presence of Isu2, which resulted in an increase in the catalytic efficiency from 25 to 
7900 M-1s-1 (Table 2-1). This increase in catalytic efficiency was due to a nearly 6-fold 
faster kcat for sulfide production and a change in KM for cysteine from 0.59 to 0.011 mM. 
Because the physiological concentration of cysteine in eukaryotic cells is thought to be 
 
 
FIGURE 2-1: Human cysteine desulfurase Nfs1 activity with (A) Isu2 or Fxn. (B) Isu2 and Fxn in the 
absence or presence of ferrous iron 
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0.1 mM (119-121), the cysteine desulfurase activities were determined at this 
concentration to mimic cellular conditions. The sulfide production activity for SD was 
similar when either Isu2 or Fxn was individually added but dramatically increased when 
both were present (Figure 2-2A). Together, these data indicate that Fxn greatly 
stimulates the cysteine desulfurase in an Isu2-dependent manner, facilitating catalysis at 
physiological cysteine concentrations. 
  
 
 
 
 
 
FIGURE 2-2: Frataxin and ferrous iron stimulate cysteine desulfurase activity. (A) Rates of SD sulfide 
production were determined in the presence of 3 equivalents of Isu2, 3 equivalents of Fxn, and either 
0 or 10 equivalents of ferrous iron. Equivalents are calculated based on the concentration of SD. For 
the oxidized sample, SD was incubated with Isu2 and Fxn for 30 minutes in air and then the reaction 
was initiated with cysteine and DTT. Error bars are for three independent measurements. (B) Rates of 
sulfide production were determined for SD in the presence of 3 equivalents of Isu2 and Fxn, and 
increasing amounts of ferrous iron. 
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Given the iron dependent of Fxn–Isu interactions (16, 108, 122), the ferrous iron 
dependence of the kinetics of sulfide production was explored. Iron had little effect on 
the cysteine desulfurase activities of SD, SD with Isu2, and SD with Fxn (Figure 2-2A). 
In contrast, iron stimulated the activity of SD when both Isu2 and Fxn were present; 
kinetics analysis revealed that this increase in activity was due to a doubling of the kcat 
rate rather than a significant change in the KM (Table 2-1). A reaction mixture containing 
SD, Isu2, and Fxn was titrated with iron, and the maximal activity was achieved after the 
  
 
 
addition of 1 equiv of iron (Figure 2-2B). A similar SD, Isu2, and Fxn reaction was not 
 
 
FIGURE 2-3: Stimulation of cysteine desulfurase activity by metal ions. Rates of sulfide production 
were determined for SD in the presence of 3 equivalents of Isu2 and Fxn, and 10 equivalents of metal 
ions. 
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significantly stimulated by ferric iron and other first row transition metals, with the 
possible exception of Mn2+ (Figure 2-3). Together, these data indicate that both Isu2 and 
Fxn are necessary for the activation of the SD cysteine desulfurase, which can be further 
stimulated by 1 equiv of ferrous iron. 
Human Frataxin Accelerates Fe–S Cluster Assembly. Fe–S cluster biosynthesis 
rates were determined by following the increase in absorbance at 456 nm, commonly 
used to monitor [Fe2S2] cluster formation (117), in the presence of 0.1 mM cysteine and 
0.1 mM Fe2+. An assay containing SD with Isu2 exhibited a specific activity of 0.0027 
unit/mg, whereas addition of Fxn increased the rate by a factor of 25 (Figure 2-4A). 
  
 
 
 
FIGURE 2-4: Frataxin accelerates the rate of Fe-S biosynthesis. (A) Fe-S cluster formation was 
monitored by an increase in absorbance at 456 nm as a function of time. Assays included SD with 3 
equivalents of Isu2, and SD with 3 equivalents of both Isu2 and Fxn. (B) The rate of Fe-S 
biosynthesis was determined as a function of added Fxn. 
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Titration of Fxn into a reaction mixture containing SD and Isu2 revealed that the specific 
activity increased linearly with added Fxn and was maximal after the addition of 1 equiv 
of Fxn and SD (Figure 2-4B). These results revealed that Fxn stimulates formation of 
Fe–S clusters on Isu2 and indicated that Fxn functions as an activator for human Fe–S 
cluster biosynthesis. 
Human Nfs1, Isd11, Isu2, and Fxn Form a Multiprotein Complex. Because Isu2 
and Fxn together dramatically changed the kinetic parameters of the cysteine desulfurase 
(Table 2-1), we hypothesized that Nfs1, Isd11, Isu2 and Fxn may form a multiprotein 
complex. To test this hypothesis, SD, Isu2, and Fxn were incubated with 5–10 mM DTT 
in an anaerobic glove box for 30 min and then tested for protein–protein interactions 
using native gel electrophoresis (Figure 2-5A). Addition of all four proteins resulted in 
the appearance of a slower migrating band compared to Fxn on the native gel that was 
consistent with formation of a protein complex. The slower migrating band was 
dependent upon the presence of each of the protein components (Figure 2-5A). This 
protein complex formed in the presence of 10 mM EDTA and the addition of ferrous 
iron had no obvious affect on band intensity. Cutting this band out of the native gel and 
analyzing with SDS–PAGE revealed the presence of all four added proteins (Figure 2-
5B). This slower migrating band on the native gel was therefore associated with a non-
covalent Nfs1, Isd11, Isu2, and Fxn protein complex (SDUF) that was stable in the 
presence of metal chelators. 
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Next, protein titration experiments were performed to probe the requirements for 
complex formation and provide an indication of the subunit stoichiometry. First, 0–3 
equiv of Fxn was added to a mixture of SD and 3 equiv of Isu2, followed by native gel 
electrophoresis to monitor SDUF formation (Figure 2-6A). The slower migrating band 
was not observed in the absence of Fxn, increased in intensity with added Fxn, and was 
maximal after the addition of 1 equiv of Fxn (Figure 2-6B). Similarly, Isu2 was titrated 
into a mixture of SD and 3 equiv of Fxn (Figure 2-7A). The slower migrating band was 
not formed in the absence of Isu2, increased with added Isu2, and was maximal after the
  
 
 
FIGURE 2-5: Nfs1/Isd11, Isu2, and Fxn form a multiprotein complex. (A) Native gel showing protein 
requirements for complex formation. Lane1: Isu2 (Isu2 has an estimated pI of 8.9 and is difficult to 
observe under the native gel conditions); 2: Fxn; 3: SD; 4: SD + Fxn; 5: SD + Isu2; 6: Isu2 + Fxn; 7: 
SD + Isu2 + Fxn; 8: SD + Isu2 + Fxn - DTT; 9: SD + Isu2 + Fxn + EDTA; 10: SD + Isu2 + Fxn + 
Fe2+. An asterisk (*) and diamond (♦) mark the positions of the slower migrating band and Fxn, 
respectively. (B) SDS-PAGE gel showing the protein components of the slower migrating band. The 
band from (A) was extracted and analyzed by SDS-PAGE. 
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FIGURE 2-6: Fxn induces formation of the SDUF complex. (A) Native gel showing SDUF complex 
formation with added Fxn. Lane 1: Isu2; 2: Fxn; 3: SD; 4-14: SD + Isu2 with 0-3 equivalents of Fxn. 
An asterisk (*) and diamond (♦) mark the positions of the SDUF and Fxn, respectively. (B) One 
equivalent of Fxn is required to form the SDUF complex. Densitometry was used to quantitate the 
SDUF band from (A). 
 
 
FIGURE 2-7: Isu2 induces formation of the SDUF complex. (A) Native gel showing SDUF complex 
formation with added Isu2. Lane 1: Isu2; 2: Fxn; 3: SD; 4-14: SD + Fxn with 0-3 equivalents of Isu2. 
An asterisk (*) and diamond (♦) mark the positions of the SDUF and excess Fxn, respectively. (B) 
Densitometry was used to quantitate the SDUF band from (A). 
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addition of 2 equiv of Isu2 (Figure 2-7B). These experiments further supported SD, Isu2, 
and Fxn as components of the protein complex associated with the slower migrating 
band and placed an upper limit on the stoichiometry at one Fxn and two Isu2 subunits 
for each SD. 
Oxidizing Conditions Inhibit Complex Formation. The redox requirements for 
complex formation and Fxn-dependent activation were determined. First, a native gel  
assay was used to determine that in the absence of a reducing agent (DTT or TCEP), the 
intensity of the slower migrating band was diminished (Figure 2-5A, lane 8). Second, a 
SD sample was incubated with Isu2 and Fxn in air for 30 min, DTT and cysteine were 
added, and the cysteine desulfurase activity was measured. This air-oxidized sample 
exhibited diminished cysteine desulfurase activity compared to the equivalent anaerobic 
sample with all four components (Figure 2-2A). Together, the data indicated a 
correlation between SDUF formation and activation of the Fe–S cluster assembly 
machinery that was influenced by redox conditions. 
Nfs1, Isd11, Isu2, and Fxn Form ~ 150–180 kDa Complexes. Analytical gel 
filtration chromatography was used to estimate the oligomeric state and molecular 
weight of the human proteins and complexes. SD, Isu2, and Fxn exhibited retention 
times consistent with estimated molecular weights of 150, 17, and 17 kDa, respectively 
(Figure 2-8A). Gel filtration chromatographic analysis of SD incubated with both Isu2 
and Fxn revealed an apparent 180 kDa species (Figure 2-8A). SDS–PAGE analysis 
revealed the presence of Nfs1, Isd11, Isu2 and Fxn (Figure 2-8B), which was consistent
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with SDUF. Interestingly, gel filtration analysis of a SD sample incubated with Isu2 
resulted in a slightly different retention time and an estimated molecular weight of 170 
kDa (Figure 2-8A). SDS–PAGE analysis of the 170 kDa fractions revealed the presence 
of Nfs1, Isd11, and Isu2, consistent with SDU. In contrast, a similar experiment with SD 
incubated with Fxn provided no evidence of SDF (Nfs1, Isd11, and Fxn protein 
complex). The formation of SDU and not SDF was consistent with the perturbation of 
the SD kinetic parameters upon addition of Isu2 or Fxn (Table 2-1). No higher-
molecular weight species or aggregate, such as oligomeric Fxn, was observed in these 
experiments. These gel filtration results were consistent with human Nfs1, Isd11, and 
 
 
FIGURE 2-8: Molecular mass estimates and protein components for SD, SDU, and SDUF complexes. 
(A) Three equivalents of Isu2 were added to SD to generate the SDU complex. Three equivalents of 
both Isu2 and Fxn were added to SD to form the SDUF complex. Samples were analyzed with 
anaerobic gel filtration chromatography. (B) SDS-PAGE analysis of Fe-S cluster assembly 
complexes confirms protein components. 
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Isu2 assembling into SDU, and Nfs1, Isd11, Isu2, and Fxn assembling into SDUF in 
which Fxn binding depends on the presence of Isu2. 
 
DISCUSSION 
 Human Fe–S cluster assembly proteins were isolated and conditions discovered 
for forming previously uncharacterized SDU and SDUF comprised of Nfs1, Isd11, and 
Isu2 and Nfs1, Isd11, Isu2, and Fxn, respectively. Previously, a protein complex was 
proposed for Fe–S cluster biosynthesis in yeast that included oligomeric rather than 
monomeric Fxn (123). Gel filtration results presented here (Figure 2-8A) revealed no 
evidence of oligomeric Fxn and confirmed human Fxn is in the monomeric form. 
Together, these data suggest that SDU and SDUF have molecular weights of 
approximately 170–180 kDa, represent distinct functional states for Fe–S cluster 
biosynthesis (see below), and are the mechanistically relevant species for future study.  
SDU is essentially inactive at physiological cysteine concentrations. The 
concentration of cysteine in mouse liver or brain homogenates is reported to be 0.1 mM 
(119). The concentration of cysteine in rate liver mitochondria was originally 
undetectable (124, 125), but recent studies revealed a concentration of 0.07 mM (121). 
Kinetics analysis of human SDU (SD and Isu2) using 0.1 mM cysteine revealed very 
low sulfide production and Fe–S cluster biosynthetic activities (Figure 2-2A and 2-4A). 
The modest activities are explained by the low “physiological” substrate concentration 
(0.1 mM) compared to the high KM (0.59 mM) for human SDU. We proposed SDU is in 
the “off” state for Fe–S cluster assembly. 
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Binding of Fxn to SDU generates an ~180 kDa SDUF species with a possible 
α2β2γ2δ2 stoichiometry. A recent crystal structure revealed that a bacterial IscS (Nfs1 
homologue) binds to IscU (Isu2 homologue) with an elongated α2β2 stoichiometry (44). 
Titration results indicated that each Nfs1 binds a maximum of one Fxn (Figure 2-6B). If 
we assume each Nfs1 also binds one Isd11, the resulting α2β2γ2 for SDU and α2β2γ2δ2 for 
SDUF have calculated molecular weights of 144 and 172 kDa, respectively, which are 
close to the estimated masses (170 and 180 kDa, respectively) determined by gel 
filtration chromatography (Figure 2-8A).  The similar retention times for SDU and 
SDUF are consistent with the elongated architecture for the bacterial IscS–IscU 
structure, and a model suggesting a more globular IscS–IscU–Fxn species (44). 
Together, these results suggest α2β2γ2 SDU and α2β2γ2δ2 SDUF stoichiometries but do 
not rule out alternate stoichiometries with additional Isd11 and Isu2 molecules. 
Fxn binding and stimulation of cysteine desulfurase activity are reminiscent of 
sulfur acceptor proteins in bacterial systems. Fxn binding to SDU increased the sulfide 
production activity 20-fold (Figure 2-2A). Stimulation of cysteine desulfurases by 
binding partners is well-known. In E. coli, IscS activity is stimulated 6-fold by IscU 
binding (89) and SufS activity is increased 50-fold by SufE interactions (126). SufE is a 
sulfur transfer protein (92) that is structural similar to IscU (127). In bacillus subtilis, the 
scaffold apo-protein SufU stimulated SufS activity 40-fold, whereas the cluster-bound 
SufU stimulated SufS at a much lower level (128). Cysteine desulfurases are also 
stimulated by molecular chaperones involved in Fe–S cluster assembly (129) and 
proteins involved in tRNA (130) and molybdopterin (42) biosynthesis. 
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Fxn binding activates SDU, possibly through a conformational change. Fxn 
binding increased the kcat nearly 6-fold and decreased the KM for cysteine by more than 
50-fold (Table 2-1). Because there is no evidence that Fxn directly participates in 
cysteine desulfurase catalysis, we suggest Fxn acts indirectly as an allosteric activator 
and induces a conformational change that positions Nfs1 persulfide loop and a conserved 
cysteine on Isu2 for direct sulfur transfer and Fe–S cluster biosynthesis. In this model 
(Figure 2-9), Fxn binding to SDU switches the Nfs1 flexible loop from a nonfunctional 
to a catalytic conformation, which enhances substrate binding and lowers the KM for 
cysteine. We hypothesize that Fxn binding to SDU also induces a conformational change 
in Isu2 that facilitates the transfer of sulfur from Nfs1 and thereby increases the cysteine 
turnover number (kcat). The persulfide cleavage or sulfur transfer step is the rate-limiting 
step in other cysteine desulfurases (45). Regardless of the molecular details, the binding 
of Fxn to SDU dramatically increases the catalytic efficiency of the complex and 
essentially turns the assembly system “on” for Fe-S cluster biosynthesis at physiological 
cysteine concentrations. 
Iron enhances the ability of Fxn to activate the cysteine desulfurase. The addition 
of ferrous iron to SDUF doubles the kcat but had minimal effects on the KM for cysteine 
(Table 2-1). The maximum stimulation was observed after the addition of 1 equiv of iron 
(Figure 2-2B). Previously, 1 equiv of iron was shown to be required for Fxn and Isu 
interactions (16, 80). Iron does not appear to be required for the formation of SDUF 
(Figure 2-5A, lane 9 and 10), but a role for iron in complex stabilization has not been 
evaluated. The addition of ferric iron or most of the first row transition metals did not 
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significantly increase the cysteine desulfurase activity (Figure 2-3). The one exception is 
Mn2+, which slightly activated (128% of the control) the cysteine desulfurase activity 
and is a good mimic of ferrous iron. This result is consistent with Fe2+, and possibly 
Mn2+, functioning in conjunction with Fxn to accelerate the sulfur transfer step in 
catalysis, possibly by inducing a conformational change in Isu2. 
The addition of Fxn to SDU accelerated the rate of Fe-S cluster biosynthesis 25-
fold at physiological cysteine concentrations. In this experiment (Figure 2-4A), the 
absorbance maximized after a calculated 12 µM [Fe2S2] cluster was formed, which is 
approximately the concentration (8 µM) of SDUF. This calculation is based on the 
assumption that the absorbance at 456 nm is due to [Fe2S2] clusters with an extinction 
coefficient of 5.8 mM-1cm-1 (117); this [Fe2S2] cluster assignment should be viewed as 
tentative until it is supported by additional spectroscopic studies. Strikingly, addition of 
Fxn to SDU results in mirrored increases in the rate of Fe–S cluster biosynthesis (Figure 
2-4B) and the amount of SDUF formation (Figure 2-6B), with both exhibiting a 
maximum effect after the addition of 1 equiv of Fxn. These data strongly support a 
model in which Fxn is an activating component of the core Fe–S cluster assembly 
machine (Figure 2-9). 
An allosteric activator role for Fxn in Fe–S cluster biosynthesis is consistent with 
most previous studies. This newly discovered function for Fxn is consistent with in vivo 
experiments that show Fxn depletion results in the loss of activity for Fe–S cluster 
enzymes (103, 104). Enzyme assay results (Figure 2-4) indicate that SDU is still able to
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synthesize Fe–S clusters in the absence of Fxn, albeit at a much lower rate. This explains 
the residual level of Fe-S enzyme activity in Fxn-depleted yeast mitochondria (107). A 
role for Fxn as an allosteric activator for Fe-S cluster biosynthesis is also consistent with 
the neurodegenerative and cardiovascular impairment in Friedreich’s ataxia (FRDA). 
FRDA patients with low frataxin levels would be expected to contain only residual or 
“unactivated” levels of Fe-S cluster biosynthesis, have depleted Fe-S clusters in their 
respiratory chain, and exhibit mitochondrial dysfunction. Because heart and brain tissue 
are especially rich in mitochondria, these tissues are particularly susceptible to Fxn 
deficiencies and Fe-S cluster defects. This allosteric activator role for human Fxn is in 
contrast to studies of the E. coli homologue that suggest Fxn functions as an inhibitor for 
Fe-S cluster biosynthesis (80). An allosteric activator function for Fxn does not 
 
 
FIGURE 2-9: Working model for Fxn activation of the Fe-S cluster assembly complex. The Nfs1 
flexible loop is stabilized in a non-functional conformation for the SD and SDU complexes. Fxn 
binding favors the catalytic loop conformation, enhances substrate binding, and accelerates persulfide 
bond formation.  Fxn and Fe binding also induce a conformational change in Isu2 that accelerates 
sulfur transfer from Nfs1 to Isu2 for Fe-S cluster biosynthesis. 
 48 
necessarily rule out other functions, such as mediating iron delivery for Fe-S cluster 
synthesis. 
Fxn levels in vivo may be used to regulate the Fe-S cluster assembly activity in 
response to environment stimuli. The results presented here clearly indicate Fxn is an 
activating component for SDUF Fe-S cluster assembly complex. What is unclear is if 
Fxn protein levels are controlled by environmental cues as a mechanism for regulating 
Fe-S cluster biosynthesis. Fxn protein levels are known to vary by a factor of > 3 in 
normal individuals (131). Two possible environmental stimuli are iron and oxidative 
stress. Iron regulates Fxn expression (81) and stimulates Fe-S cluster biosynthesis in a 
Fxn-dependent manner (Figure 2-2B). Oxidative stress results in chemical modification 
of Fxn (86), whereas oxidizing conditions weaken SDUF formation (Figure 2-5A, lane 
8) and Fxn-based activation (Figure 2-2A). Additional experiments are required to 
determine if these or other environmental stimuli are part of a regulatory mechanism that 
uses Fxn to modulate Fe-S cluster biosynthesis. 
Here we establish that a four-protein component complex that includes Nfs1, 
Isd11, Isu2, and Fxn is capable of synthesizing Fe-S clusters. Future studies are required 
to clarify if this SDUF interacts transiently with additional biosynthetic components, 
such as the electron donor (ferredoxin) and iron donor machinery, or if an even larger 
assembly complex is formed. Additional studies are also required to determine if the 
molecular chaperones, which facilitate transfer of Fe-S cluster to apo target proteins, 
interact with SDUF, a subcomplex such as SDU, or dissociated holo-Isu2. In addition, 
few details are currently available for the mechanisms of human [Fe2S2] and [Fe4S4] 
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cluster assembly, target recognition, and cluster transfer. The results presented here 
provide strong evidence that SDU and SDUF represent the off and on states for Fe-S 
cluster biosynthesis, respectively, lead to testable hypotheses for cellular regulation of 
Fe-S cluster assembly, and provide a foundation for addressing these mechanistic 
questions. 
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CHAPTER III 
 FRATAXIN-DEPENDENT SULFUR TRANSFER MECHANISM FOR THE 
HUMAN FE-S CLUSTER BIOSYNTHETIC COMPLEX 
 
INTRODUCTION 
 Sulfur is a critical element for all life forms and is found in a variety of protein 
cofactors including molybdopterins, lipoic acid, thiamin, biotin, and iron-sulfur clusters. 
Even though these cofactors are functionally well understood, mechanistic details are 
just emerging for how sulfur is incorporated into these biomolecules (41, 132). A 
common early step for these pathways is the cysteine desulfurase dependent degradation 
of cysteine to alanine and generation of a protein-bound persulfide species. The activated 
persulfidic sulfur is reductively cleaved by distinct acceptor proteins for the biosynthesis 
of sulfur-containing cofactors and modification of tRNA (41). Redox agents such as 
cysteine and DTT (in vitro) can also release the persulfidic sulfur in a rate-limiting step 
that produces hydrogen sulfide (15, 45).  
In prokaryotic Fe-S cluster biosynthesis, a cysteine desulfurase IscS forms a 
complex with a scaffold protein IscU to facilitate sulfur transfer and Fe-S cluster 
assembly (94, 97). IscS catalyzes the PLP-dependant cleavage of the C-S bond of its 
cysteine substrate to form alanine and a persulfide species on residue C328 (46).  
Remarkably, a recent IscS-IscU crystal structure revealed that C328 is located on a 
highly flexible loop that appears to sample a distance of ~30 Å by interacting with both 
the IscS substrate-PLP adduct and conserved cysteines on IscU (44). The IscU cysteines 
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C37 and C63 are located on loops at the IscS-IscU interface, whereas C106 is somewhat 
buried on the C-terminal helix of IscU (Figure 1-11). Although the functional 
significance for sulfur transfer is unclear, disulfide crosslinks between IscS C328 and 
IscU residues C37 (90) and C63 (89) confirm that these IscU residues can interact with 
the flexible loop of IscS. Mass spectrometry data for the A. vinelandii system indicates 
that all three IscU variants can function as sulfur (or polysulfide) acceptors (90). Kinetic 
data for the E. coli ISC system revealed that native, C37S, and C106S, but not C63S, 
IscU are able to stimulate IscS activity (89), suggesting C63 attacks the C328 persulfide 
on IscS. 
In eukaryotes, recent evidence suggests Fe-S biosynthesis occurs through an 
assembly complex that exists in at least two forms: a mostly inactive complex of Nfs1, 
Isd11, Isu2 (SDU) and an activated complex of Nfs1, Isd11, Isu2, and frataxin (SDUF) 
subunits (52).  In humans, the 94 kDa homodimeric cysteine desulfurase Nfs1 (homolog 
of IscS) provides sulfur for Fe-S cluster biosynthesis (15, 43) on the 14 kDa scaffold 
protein Isu2 (homolog of IscU).  Isd11 is an 11 kDa eukaryotic-specific protein that 
interacts and stabilizes Nfs1 (49, 50, 112).  Frataxin (Fxn) has been intensively studied 
since it was discovered that its depletion is associated with the neurodegenerative 
disease Friedreich’s ataxia (37).  The mature form of Fxn (residues 81-210) has been 
proposed to function as an allosteric activator (52) and as an iron donor for Fe-S cluster 
assembly (16, 99, 100).  Little is known about the eukaryotic hand-off mechanism from 
Nfs1 to Isu2 and the role of Fxn in this process.  Here we present enzyme kinetic data 
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that indicate human Fxn induces a conformational change in Isu2 that positions C104 to 
attack the persulfide species on Nfs1 for sulfur transfer and Fe-S cluster biosynthesis.  
 
EXPERIMENTAL PROCEDURES 
 Protein Expression and Purification. Human Nfs1/Isd11, wt-Fxn, and wt-Isu2 
were expressed and purified as described on page 30–31 (52). Eight human Isu2 cysteine 
variants [C35A(S), C61A(S), C104A(S), C96S, and C35A/C61A] were created by 
QuikChange site-directed mutagenesis (Stratagene) using a pET11a-hIsu2 plasmid 
template, and the mutation sites were confirmed by DNA sequencing (Gene 
Technologies Lab at TAMU). The resulting Isu2 variant pET11a plasmids were 
transformed into BL21(DE3) cells and grown at 16 oC until reaching an OD600 of 0.5.  
Protein expression was then induced with 0.5 mM IPTG and the cells were harvested 16 
hrs later. The variants were purified using the same protocol as wild-type Isu2 (page 31). 
Undergraduate Andrew Winn and graduate student Jennifer Bridwell-Rabb assisted on 
the construction, purification, and determination of activity for the C35S, C61S, C104S, 
and C35A/C61A variants. 
  Isu2 Variant Binding to and Stimulation of Fe-S Assembly Complex. The rate of 
sulfide production for the Nfs1, Isd11, Isu2, and Fxn (SDUF) complex was measured 
using a previously described methylene blue assay (52). For the titration of Isu2 variants, 
the reaction mixture included 0.5 µM SD, 2.5 µM Fxn, 2 mM DTT, 10 µM PLP, 50 mM 
Tris pH 8.0, 250 mM NaCl. Different amounts of Isu2 variants (0-5 µM Isu2, C35A, 
C35S, or C96S; 0-30 µM C61A or C61S; 0-10 µM C140A or C104S; 0-125 µM 
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C35A/C61A) were added in the absence or presence of 5 µM Fe(NH4)2(SO4)2, the 
samples were incubated in the anaerobic glove box for 30 min, and then the reactions 
were initiated with 100 µM L-cysteine. The number of equivalents for the Isu2 variants 
(calculated based on the SD concentration) that maximized the cysteine desulfurase 
activities were then determined to be 3 (native Isu2 and C96S), 5 (C35A), 15 (C35S), 40 
(C61A), 60 (C61S), 10 (C104A and C104S), and 100 (C35A/C61A).  These amounts of 
the Isu2 variants were then used to determine the activity under standard assay and 
Michaelis-Menten conditions. 
Determination of Kinetic Parameters for Isu2 Variants. Reaction mixtures 
included 0.5 µM SD, 2.5 µM Fxn, 2 mM DTT, 10 µM PLP, 5 µM Fe(NH4)2(SO4)2, 50 
mM Tris (pH 8.0), 250 mM NaCl, and the saturating amount of Isu2 variant (determined 
above). The samples were incubated in the glove box for 30 min prior to initiation with 
cysteine.  The cysteine concentration ranges used were 5-200 µM for native, C35A, and 
C61A variants, 25-1000 µM for C35S, C61S, C104S, and C35A/C61A, and 25–1500 
µM for C104A.  Reaction rates as a function of cysteine concentration were fit to the 
Michaelis-Menten equation using KaleidaGraph (Synergy Software).  
Cysteine Desulfurase Activities with Isu2 Variants at a Physiological Cysteine 
Concentration (0.1 mM). The cysteine desulfurase activities were determined at 0.1 mM 
cysteine concentration with 0.5 µM SD, 2 mM DTT, 10 µM PLP, 50 mM Tris pH 8.0, 
250 mM NaCl, and saturated amounts of Isu2 variants in the absence or presence of 5 
µM Fe(NH4)2(SO4)2. Three independent measurements were conducted and averaged. 
Similar experiments were also performed with 3 equivalents (2.5 µM) Fxn. 
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RESULTS 
Conserved Cysteines on Isu2 Contribute to Binding the SDUF Complex. Eight 
mutants of Isu2 were constructed to examine the sulfur transfer mechanism for the 
human Fe-S cluster assembly complex.  The three conserved cysteines (C35, C61, and 
C104) were each mutated to alanine and serine, whereas the nonconserved cysteine 
(C96) was mutated to serine.  In addition, the double mutant C35A and C61A variant 
was constructed.  These mutants were individually added into an assay mixture that 
included Nfs1, Isd11, and Fxn, the cysteine desulfurase reaction was initiated with 100 
µM cysteine, and the sulfide produced was converted into methylene blue and 
quantitated.  
The addition of increasing amounts of the Isu2 variants increased the sulfide 
production rate that then plateaued at different total activities. This saturation behavior 
was interpreted as binding phenomenon in which the addition of Isu2 generates the 
catalytically active SDUF complex, and that the Isu2 variants have distinct binding 
affinities and ability to activate the complex. Native Isu2 and C96S (not shown) required 
3 equivalents to saturate the cysteine desulfurase activity (Figure 3-1A). The addition of 
the C104A and C104S variants had little effect on the cysteine desulfurase activity 
(Figure 3-1A).  The C104S variant slightly increased and the C104A variant slightly 
decreased activity. These changes in activity appeared to be complete after the addition 
of 10 equivalents of Isu2.  The C35A variant saturated after 5 equivalents (Figure 3-1A), 
whereas the C35S variant required 15 equivalents (Figure 3-1B). The C61A and C61S
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Isu2 saturated at 40 and 60 equivalents, respectively (Figure 3-1C). Finally, the double 
mutant C35A/C61A required 200 equivalents to saturate the cysteine desulfurase activity 
(Figure 3-1D). Together this data indicates that mutation of any of the three conserved 
cysteines for Isu2 resulted in weaker binding, and that C61 has the largest role in 
complex formation.  
 Scheme for the Sulfide Rate Enhancement by Isu2 and Fxn.  Previously, the rate 
of sulfide production from Nfs1 was shown to be stimulated by the presence of Isu2 and 
Fxn (52). We propose the simplified figure 3-2 to explain the rate enhancement. In the 
absence of Fxn, we hypothesize that internal sulfur transfer from Nfs1 to Isu2 either does 
not occur or occurs at a minimal rate compared to sulfide release from the Nfs1 
persulfide loop by DTT (reaction [1]).  In the presence of Fxn, we hypothesize that 
internal transfer from Nfs1 to Isu2 (reaction [2]) is favored and that the sulfide is release
  
 
 
FIGURE 3-1: Cysteine desulfurase activity measurement with the titration of Isu2 variants in the 
presence of Fxn and ferrous iron. The molar ratio is compared to SD. The assay contains SD, Fxn, 
DTT, ferrous iron, PLP, cysteine (100 µM), and Isu2 variants. (A) WT-, C35A-, C35S-, C014A-, and 
C104S-Isu2 (B) C35S-Isu2 (C) C61A- and C61S-Isu2 (D) C35A/C61A-Isu2 double mutant. 
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from a persulfide on Isu2 at a faster rate than from Nfs1 (reaction [3] > [1]). This scheme 
explains the overall rate enhancement for sulfide production by Fxn and predicts that if 
the sulfur acceptor on Isu2 were removed the rate enhancement by Fxn would be lost. 
Sulfur Transfer from Nfs1 to Isu2 Residue C104. Here the cysteine desulfurase 
activities for the 8 different Isu2 variants were determined in the presence of Fxn. 
Saturating amounts of Isu2 (Figure 3-1) and 5 equivalents of Fxn/SD were used in these 
assays to remove complications from weaker binding of Isu2 variants to the SDUF 
complex. The C35A and C35S Isu2 mutants exhibited similar Fxn-dependent stimulation 
of Nfs1 activity (80% of native Isu2) using a physiological cysteine concentration of 100 
µM (Figure 3-3). Examination of the Michaelis-Menten kinetics revealed catalytic 
efficiencies (kcat/KM) of 10,500 M-1s-1 for the C35A variant and 10,800 M-1s-1 for the
  
 
 
FIGURE 3-2: Reaction scheme for sulfur transfer from Nfs1 to Isu2 in the absence and presence of 
Fxn. 
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C35S variant, which are essentially identical to the 10,100 M-1s-1 of native Isu2 (Table 3-
1). The C61A and C61S Isu2 mutants exhibited 80 and 40%, respectively, of the control 
activity under standard assay conditions (Figure 3-3).  The catalytic efficiency of the 
C61A was 9,600 M-1s-1, whereas the C61S variant exhibited a kcat/KM of 6,500 M-1s-1 
(Table 3-1). In contrast, the C104A and C104S Isu2 variants stimulated activity at about 
5 and 15%, respectively, of native Isu2 (Figure 3-3). Both of the C104 variants exhibited
  
 
 
FIGURE 3-3: Percent of SDUF activity with Isu2 variants in the presence of Fxn. A mixture contains 
SD, Fxn, DTT, ferrous iron, cysteine (100 µM), and saturated amount of Isu2 variants (except only 3 
equiv of C96S-Isu2 was used). Double means C35A/C61A-Isu2 mutations. 
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8-10 fold lower kcat than native Isu2 (Table 3-1). Interestingly, the KM for the C104A 
variant was 0.51 mM, which is significantly higher than the 0.014 mM KM for both 
native Isu2 and C104S, and similar to samples that did not contain Fxn (0.59 mM) (52). 
The slower kinetics of the C104 variants suggests that this residue may be 
involved in reaction [2] or [3]. To explore if one of the other cysteines was the initial 
acceptor and, after internal Isu2 sulfur transfer, a persulfide on C104 was generated and 
then released by DTT, the double mutant (C35A/C61A) was constructed and its kinetics 
were examined. The double mutant exhibited about 50% of the activity of native Isu2 in 
a standard assay and a catalytic efficiency of 8,100 M-1s-1 (Figure 3-3 and Table 3-1). As 
a control, the fourth non-conserved cysteine (C96) in human Isu2 was mutated to a 
serine and this variant was shown to have similar activity as native Isu2 and the C35A
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and C61A variants (Figure 3-3). Together, the kinetics results were consistent with the 
C104 residue on Isu2 serving as the primary sulfur acceptor from Nfs1 for Fe-S cluster 
assembly. 
 Fxn Facilitates Sulfur Transfer From Nfs1 to Isu2. Here the cysteine desulfurase 
activities for the 8 different Isu2 variants were determined in the absence of Fxn.  
Saturating amounts of the Isu2 variants that were determined in the presence of Fxn 
(above) were added to overcome differences in binding affinities.  The mutants all 
 
 
FIGURE 3-4: Percent SDUF activity of Isu2 variants in the absence of Fxn. The assay mixture contains 
SD, DTT, ferrous iron, cysteine (100 µM) and saturated amount of Isu2 cys variants. Double means 
C35A/C61A-Isu2 mutant. The control experiment is the assay mixture with 5 equiv of Fxn. 
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exhibited 10-15% of the sulfide production activity of the SDUF complex (Figure 3-4). 
Importantly, the Isu2 dependent differences in sulfide production activity were no longer 
apparent in the absence of Fxn. 
 
DISCUSSION 
 Despite the importance of Fe-S clusters, few details are known about their 
assembly mechanisms.  Sulfur is mobilized by a cysteine desulfurase from a cysteine 
substrate in the form of a reactive persulfide intermediate that can be transferred to a 
scaffold protein for Fe-S cluster biosynthesis. In prokaryotes, sulfur transfer from IscS to 
IscU has been suggested as the first step in Fe–S cluster biosynthesis (94). However, 
there is controversy over whether a particular cysteine, and, if so, which cysteine accepts 
the sulfur atom donated by the cysteine desulfurase for Fe-S cluster biosynthesis (90). 
To elucidate this issue, three conserved cysteine residues (C35, C61, and C104) on 
human Isu2 were investigated. First, titration of Isu2 variants was conducted to 
determine the relative binding affinities for the Isu2 variants to the SDUF complex. The 
titrations indicated that residue C61 variants on Isu2 require 40–60 equivalents to 
maximize the Nfs1 activity, which implies C61 is critical for interactions in the Fe-S 
assembly complex (Figure 3-1). Recently, a crystal structure of the E. coli IscS-IscU 
complex (44) revealed that IscS binds to IscU near C63 (equivalent to human C61) on 
IscU (Figure 3-5A). In that study, mutation of Isu2 residue K103 residue, which H-
bonds with IscS residue E311, disrupted protein-protein interactions that were monitored
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with a pull-down assay (44). Hence, the mutation of human C61, which is expected to be 
adjacent to this K103-E311 interaction, may result in a conformational change and 
weaken the binding of Isu2 to Nfs1 (Figure 3-1). At saturating amounts of the C61-Isu2 
mutants, the cysteine desulfurase activity is similar to native Isu2, suggesting the 
mutation results in weaker binding but is not catalytically compromised (Figure 3-3 and 
Table 3-1). The mutations of C35 and C104 residues on Isu2 exhibited similar binding 
characteristics, essentially 1–2-fold weaker than native Isu2 (Figure 3-1), but 
dramatically different functional properties. The C35-Isu2 mutants maintain similar 
catalytic activities as native Isu2, whereas C104-Isu2 mutants abolish Nfs1 activity 
(Figure 3-3 and Table 3-1). No stimulation on Nfs1 with C104-Isu2 mutants suggests
  
 
 
FIGURE 3-5: (A) E. coli IscS-IscU complex structure (PDB: 3LVL). IscU (cyan); IscS (green and 
cornflower blue); catalytic cysteine loop on IscS (orange). (B) Structure alignment of A. aeolicus 
IscU subunit A (PDB: 2Z7E) to E. coli IscU. A. aeolicus IscU (magenta); residues are numbered 
based on human Isu2 sequence. 
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C104 residue is important for sulfur transfer. Therefore, Isu2 double mutant 
(C35A/C61A) was made to confirm if C104 residue alone can stimulate the Nfs1 
activity. 
The Isu2 double mutant (C35A/C61A) shows a catalytic efficiency of 8,100 M-
1s-1, which is fairly close to that of native Isu2 (Table 3-1). The fact that the C35A/C61A 
double mutant, and not the C104 mutants, is stimulated by Fxn suggests C104 is the 
sulfur acceptor residue on Isu2. In the absence of Fxn, native Isu2 and its variants exhibit 
the same level of sulfide production (Figure 3-4), which implies that either the sulfur is 
not transferred from Nfs1 to Isu2 or the rate for sulfur transfer is inefficient. In both 
cases, sulfide production seen in the assay was detected because persulfide product on 
Nfs1 was cleaved directly by DTT. Therefore, the sulfur transfer mechanism was 
proposed to explain our results (Figure 3-6). In reaction (1), the SDU (Nfs1/Isd11/Isu2) 
 
 
FIGURE 3-6: Proposed sulfur transfer mechanism from Nfs1 to Isu2 in the presence of Fxn. SD 
represents Nfs1/Isd11. 
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complex represents an inactive form in which the sulfur transfer reaction from Nfs1 to 
Isu2 doesn’t occur (or occurs infrequently/inefficiently) and the Nfs1-based persulfide is 
cleaved by DTT. The resulting rate of sulfide production would therefore be independent 
of Isu2 or mutations on Isu2. This is supported by the observation that the Nfs1 activity 
is the same for the different Isu2 variants (Figure 3-4). In reaction (2), the SDUF 
(Nfs1/Isd11/Isu2/Fxn) complex represents an active form in which sulfane sulfur was 
transferred from Nfs1 to Isu2, specifically to residue C104, in the presence of Fxn. The 
persulfide-bound Isu2 was then cleaved by DTT. The rate of sulfide production is 
dependent on Fxn binding and on a specific cysteine residue on Isu2. The reaction (2) 
was supported by the results that the C104 mutant exhibited low sulfide production and 
the C35A/C61A double mutant showed high sulfide production (Figure 3-3 and Table 3-
1). These two proposed reactions are consistent with our previous results that Fxn forms 
a complex with SDU and activates Nfs1 activity (52). 
Previously, the Johnson and Dean groups proposed that there was not a specific 
cysteine on IscU that accepted the sulfur from IscS in a prokaryotic system based on 
mass spectrometry data that indicated persulfide or polysulfide species on each of the 
three cysteine-to-alanine substitutions for IscU (90). Another explanation for this data is 
that a residue such as C37 residue (equivalent of human C35), which exhibits the 
shortest distance (~12 Å) of the three cysteines to the IscS catalytic cysteine loop (Figure 
1-11 and 3-5A), could be the initial sulfur acceptor and be followed by secondary 
internal persulfide transfer to C63 and C106 (44). Nobuyoshi’s group proposed a 
different mechanism in which C63 on IscU forms a disulfide-bridge with C328 on IscS 
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and responsible for accepting the sulfur during catalysis (89). These results could be 
explained by lacking of required protein partner, Fxn, for sulfur transfer to specific 
cysteine residue on IscU or lacking of maintaining the anaerobic environment for sulfur 
transfer experiments. Cysteine is known as a reducing agent as well (45). Incubation of 
IscS and IscU alone with cysteine could result in transpersulfuration from IscS to an 
external cysteine in solution and then incorporation from persulfide-bound cysteine 
species to IscU in a nonspecific mechanism.  
 
 
 
 
The crystal structure of the trimeric A. aeolicus IscU shows IscU conformations 
in both Fe–S cluster bound (subunit B) and apo (subunits A and C) forms (58). A 
primary difference between the holo and apo conformations are a helix to coil changes in 
the C-terminal region (residues 103–109), which contains K103 (equivalent of human 
 
 
FIGURE 3-7: A working model for sulfur transfer from Nfs1 to Isu2 in the presence of Fxn. 
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K101), H106 (equivalent of human H103), and conserved C107 (equivalent of human 
C104) residues. Structure alignment of A. aeolicus apo-IscU subunit A and E. coli apo-
IscU shows that C104 (human Isu2 residue number) can undergo a helix-to-coil switch 
(Figure 3-4B). In the crystal structure of the IscU-IscS complex, residue C104 of Isu2 is 
buried on the C-terminal helix and about 18 Å away from catalytic cysteine loop on 
IscS. After helix-to-coil switch, C104 is exposed and close to catalytic cysteine loop on 
IscS. Two distinct conformations of IscU in solution were also suggested by the Vickery 
group (54). One is largely disordered (apo-form) and the other is largely ordered (metal- 
or cluster-bound form). These two states interconvert on the millisecond time scale. The 
most perturbed regions were identified as the two N-terminal strands and the C-terminal 
helix upon addition of cochaperone HscB. Taken together, we proposed a working 
model to explain how sulfur is transferred from Nfs1 to Isu2 in the presence of Fxn 
(Figure 3-7). First, the cysteine substrate is bound to PLP in the active site of Nfs1. 
Second, the substrate is convered to alanine and generates a persulfide intermediate on 
residue C328 of Nfs1. Third, Fxn binds SDU, induces the helix-to-coil switch on Isu2, 
and repositions C328 catalytic loop of Nfs1. The C-terminal coil conformation of Isu2 
exposes C104 to persulfide-bound C328 on Nfs1 for sulfur transfer. The persulfide- 
bound C104 on Isu2 is either cleaved by DTT or used for Fe–S cluster assembly. Taken 
together, the results suggest C104 residue on Isu2 is the initial and primary sulfur 
acceptor from Nfs1 in the presence of Fxn, which requires the helix-to-coil 
conformational change on Isu2. 
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CHAPTER IV 
HUMAN FRATAXIN I154F AND W155R CLINICAL VARIANTS LOSE 
ABILITY TO ACTIVATE THE FE-S BIOSYNTHETIC COMPLEX 
 
INTRODUCTION 
Friedreich’s ataxia (FRDA) is an autosomal recessive neurodegenerative disease 
caused by reduced amounts of the protein frataxin (Fxn) (37). The loss of Fxn results in 
a complicated phenotype that includes increased iron in the mitochondria, deficiencies in 
Fe-S cluster enzymes, and enhanced sensitivity to oxidative stress (64). FRDA patients 
typically present symptoms during adolescence such as progressive limb and gait ataxia 
and often die prematurely from cardiomyopathy. There is currently no cure. The 
majority (>95%) of FRDA patients are homozygous for an unstable GAA trinucleotide 
expansion in the first intron of the FXN gene (39). The repeat size ranges between 7 and 
40 for normal individuals and 66 to >1700 for FRDA patients (38, 39). Importantly, 
larger GAA repeats correlate with lower Fxn expression levels and an earlier age of 
disease onset (40). A small fraction of FRDA patients have an expanded GAA repeat on 
one allele and a point mutation on the other allele (83). In these cases, the Fxn protein 
levels do not necessarily correspond to the age of onset (39, 84).  
Most researchers agree that Fxn has a critical role in iron-sulfur (Fe-S) cluster 
assembly (103, 104). In eukaryotes, the biosynthesis of Fe-S clusters occurs in the 
matrix space of the mitochondria and includes at least a dozen proteins (33). Human Isu2 
is a 14 kDa monomer (59) that provides a scaffold for building [Fe2S2] and, possibly, 
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[Fe4S4] clusters. Human Nfs1 is a 94 kDa homodimer that catalyzes the PLP-dependent 
breakdown of cysteine to alanine and transfers the resulting sulfur species to the scaffold 
protein Isu2 (13, 43). Isd11 is an 11 kDa protein that is known to form a complex with 
Nfs1 and has an undefined but vital role for Nfs1 function (49, 50, 112).  Chaperones 
then interact with the scaffold protein and assist in delivering intact Fe-S clusters to their 
apo targets (53). Both in vivo and in vitro data support physical interactions between 
eukaryotic Nfs1, Isd11, Isu, and Fxn (16, 50, 108, 110-112).  Recently, biochemical 
evidence was provided for Nfs1, Isd11, and Isu2 (SDU) and Nfs1, Isd11, Isu2, and Fxn 
(SDUF) Fe-S cluster assembly complexes (52).  
  Multiple roles have been proposed for Fxn in Fe-S cluster biosynthesis. Fxn is 
encoded in the nucleus, imported into the mitochondria, and proteolytically processed to 
generate at least four different products (65, 133-138). A 14 kDa monomeric form 
includes residues 81-210 (referred to as Fxn in this dissertation) and is commonly 
thought to function as an iron chaperone in Fe-S cluster biosynthesis (139). A larger 
form of Fxn that includes residues 56-210 (Fxn56-210) can oligomerize and has been 
proposed to function in iron detoxification and storage (71, 105), and as an iron donor 
for Fe-S cluster biosynthesis (66, 123). A negative regulator role in Fe-S cluster 
biosynthesis has also been proposed for Fxn based on functional studies of the 
Escherichia coli homolog CyaY (80). In contrast, a positive allosteric activator role for 
human Fxn was proposed based on the Fxn-dependent ~400 fold increase in catalytic 
efficiency (kcat/KM) for the cysteine desulfurase component of the Fe-S assembly 
complex (52). 
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Understanding how Fxn missense mutations such as I154F and W155R compare 
to native Fxn may provide additional insight into its role in Fe-S cluster biosynthesis.  
FRDA patients with missense Fxn mutations I154F and W155R have similar expression 
levels (18% of native Fxn), yet the age of disease onset (4 for W155R patient; 16 for 
I154F patient) are dramatically different (84). The I154F and W155R variants are 
reported to have decreased thermodynamic stability (85), and diminished binding to 
Isd11 (110) and Isu1 (88). Incorporation of I154F into a mouse model system results in a 
FRDA like phenotype that included the loss of iron-sulfur cluster enzyme activity (140). 
Surprisingly, functional analysis of the E. coli W61R (equivalent of human W155R) 
indicates enhanced activity compared to native Fxn (80). It is difficult to reconcile the 
decreased iron-sulfur cluster activity for human FRDA clinical variants in a mouse 
model system and also increased iron-sulfur cluster activity for FRDA-related mutants of 
a bacterial homolog. To address this issue, we extended previous in vitro cysteine 
desulfurase and Fe-S cluster assembly assays (52) and show that the human I154F and 
W155R and related Fxn mutants lose the ability to bind and activate the Fe-S assembly 
complex in a manner that corresponds to the clinical phenotype. Structure-function 
analysis of W155R, W155A, and native Fxn coupled to results from an associated sulfur 
trafficking manuscript (Chapter III) lead to a model for Fxn-induced sulfur transfer from 
Nfs1 to Isu2 for human Fe-S cluster biosynthesis. 
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EXPERIMENTAL PROCEDURES 
 Protein Expression and Purification. The expression and purification procedures 
for Nfs1/Isd11 complex, Isu2, and wt-Fxn were described as page 30–31. Fxn mutants 
(I154F, W155R, W155A, and W155F) were made by site-directed mutagenesis from 
pET11a-f-Fxn plasmid (page 31) using standard protocol and the mutation sites were 
confirmed by DNA sequencing. Plasmid pET11a containing I154F, W155R, W155A, 
and W155F-Fxn, individually, was then transformed into BL21(DE3) cells. Fxn mutants 
were expressed at 16 oC with 0.5 mM IPTG for 16 hrs and purified using the same 
protocol as wt-Fxn (page 31). 
 Cysteine Desulfurase Activity Assay with 3 Equiv. of Fxn Variants. Reaction 
mixtures containing SD (0.5 µM), Isu2 (1.5 µM), PLP (10 µM), DTT (2 mM), 
Fe(NH4)2(SO4)2 (5 µM), Fxn variants (1.5 µM), 50 mM Tris pH 8.0, and 250 mM NaCl 
were incubated in the anaerobic glovebox (10~14 oC) for 30 min before addition of L-
cysteine substrate (100 µM). The reaction was incubated at 37 oC anaerobically for 10 
min and then quenched by addition of 100 µL DPD (20 mM) in 7.2 M HCl and 100 µL 
FeCl3 (30 mM) in 1.2 M HCl. The methylene blue product was formed after 20 min 
incubation at 37 oC. The absorption at 670 nm corresponding to methylene blue 
formation was measured for quantization of H2S production by comparing with Na2S 
standard curve.  
 Cysteine Desulfurase Activity Assay with the Titration of Fxn Variants. Similarly, 
cysteine desulfurase activity assay was conducted with the titration of Fxn variants in the 
presence of 10 equiv of Fe(NH4)2(SO4)2. The same reaction mixtures described above 
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were titrated with Fxn variants to obtain the maximum cysteine desulfurase activity. The 
cysteine desulfurase activity was saturated after addition of 3 equiv of wt-Fxn, 8 equiv of 
I154F, 40 equiv of W155R, 40 equiv of W155A, and 30 equiv of W155F, separately. 
The similar experiments were performed in the absence of Fe(NH4)2(SO4)2. The 
resulting saturation of cysteine desulfurase activity was 5 equiv for wt-Fxn, 25 equiv for 
I154F-Fxn, 45 equiv for W155R-Fxn, 50 equiv for W155A-Fxn, and XX equiv for 
W155F-Fxn. 
 Binding Constant Determination for Fxn Variants to SDU Complex. The 5 ~ 8 
different concentrations within saturated amount of Fxn variants were mixed with 
reaction mixture (0.5 µM SD, 1.5 µM Isu2, 10 µM PLP, 2 mM DTT, 5 µM 
Fe(NH4)2(SO4)2, 50 mM Tris pH 8.0, and 250 mM NaCl), separately, for 30 min 
anaerobically. The cysteine desulfurase activity was measured after initiation with 0.01 ~ 
1 mM L-cysteine substrate. The kcat and KM for each Fxn variant concentration was 
calculated by fitting into Michaelis-Menten equation. kcat versus Fxn variant 
concentration was plotted and fitted with type II allosteric activation equation 4.1 (141).
  
€ 
kcat =
kSDU + kSDUF∞
Fxn[ ]
Kd
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟ 
1+ Fxn[ ]Kd
      (4.1) 
 
Kd is the dissociation constant; kSDU is the kcat in the absence of Fxn; and kSDUF∞ is the 
kcat in the saturated amount of Fxn.  
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Fe-S Cluster Formation Assay. Assay mixtures in 0.2 mL contained 8 µM SD, 24 
µM Isu2, 24 µM Fxn variants, 5 mM DTT, 200 µM Fe(NH4)2(SO4)2, 100 µM L-cysteine, 
50 mM Tris, pH 8.0, and 250 mM NaCl. The Isu2 was incubated with DTT and buffer in 
anaerobical glovebox for 1 hr before the remaining reaction components were added. 
100 µM L-cysteine was injected 1 cm pathlength anaerobic cuvette with gas-tight 
syringe to start the reaction. The Fe-S cluster formation was monitored at 456 nm at 
room temperature for 90 min. The rate of Fe-S cluster formation was fitted to first-order 
kinetics using KaleidaGraph. The rate was converted to specific activity of Isu2 using 
extinction coefficient 5.8 mM-1cm-1 (117). Units are defined as the amount of Isu2 
required to produce 1 µmol of [Fe2S2] cluster per minute at 25 oC. 
Crystallization, Data Collection, and Refinement of WT, W155R, and W155A-
Fxn. Crystallization conditions were setup using hanging-drop vapor diffusion methods 
by mixing 2 µL of protein with 2 µL of reservoir solution and stored at 22 oC incubator. 
WT-Fxn (15 mg/mL) in 50 mM HEPES pH 7.5 and 50 mM NaCl was crystallized in 
30% 2-Methyl-2,4-pentanediol, 0.1 M sodium citrate pH 5.6, and 0.2 M ammonium 
acetate after 1 month. ; W155R-Fxn (25 mg/mL) in 25 mM HEPES pH 7.5 was 
crystallized in 16% PEG monomethyl ether 2000 and 0.1 M MES pH 6.0 after 2~3 days; 
and W155A-Fxn (10 mg/mL) was crystallized in 1.8 M ammonium sulfate, 0.2 M 
potassium sodium tartrate tetrahydrate, and 0.1 M sodium citrate tribasic dihydrate pH 
5.0 with seeding solution from higher precipitant (2 M ammonium sulfate). The WT-Fxn 
single crystal was flash frozen in liquid nitrogen without adding extra cryo-protecting 
reagents; W155R-Fxn single crystal was transferred into cryo-protecting solution 
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containing 16% ethylene glycol and reservoir solution and then flash frozen in liquid 
nitrogen; and W155A-Fxn single crystal was transferred into cryo-protecting solution 
containing 20 % glycerol and reservoir and then flash frozen in liquid nitrogen. The x-
ray diffraction data for WT and W155R-Fxn crystal were collected on the detector 
ADSC Quantum-315R CCD at the SSRL Beamline 7-1, and W155A-Fxn crystal 
diffraction data was collected on MAR 300 CCD at APS beamline 23-ID-D. The 
collected images were integrated and scaled using iMosflm (30) and Scala (64) 
programs. The crystal resolution cut off was based on the criteria of I/(σI) ≥ 2. For WT-
Fxn, the resolution cutoff is 1.30Å in space group P212121 with one molecule per 
asymmetric unit and crystal contained 46% solvent content. For W155R-Fxn, the 
resolution cutoff is 1.31Å in space group P212121 with one molecule per asymmetric unit 
and crystal contained 46% solvent content. For W155A-Fxn, the resolution cutoff is 1.50 
Å in space group C2 with one molecule per asymmetric unit and crystal contained 46% 
solvent content. The structure of Fxn variants was determined by molecular replacement 
with human frataxin (PDB code: 1EKG) as the initial search model using Phaser (39) 
program. The output model was refined with rigid body and restrained refinement along 
with anisotropic temperature factors using Refmac5 (142) program and built by Xfit (54) 
programs. The Rwork/Rfree for WT, W155R, and W155A-Fxn structures were refined to 
15.3/18.7, 15.1/19.7, and 16.9/19.2, respectively. 
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RESULTS 
 Fxn Variants I154F and W155R(A)(F) Lose Ability to Activate Fe-S Cluster 
Biosynthetic Complex. Previously, the binding of native Fxn was shown to activate the 
Nfs1/Isd11/Isu2 complex for sulfide production for Fe-S cluster assembly, and the 
addition of ferrous iron further stimulated this activity (52). In this assay, cysteine was 
converted to alanine and the resulting persulfide intermediate was reduced with DTT, 
and the resulting sulfide was converted to methylene blue and quantitated.  Here we 
compared the ability of native Fxn, the recombinant FRDA I154F and W155R variants, 
and W155A and W155F variants to activate the Nfs1/Isd11/Isu2 complex using a 
physiological cysteine concentration of 0.1 mM (119, 121). The reason that we chose 
I154F and W155R FRDA mutants is because they have the similar expression levels in 
FRDA patients (17.6% and 17.9% of control, respectively), but the patients with W155R 
point mutation showed a more severe phenotype than I154F (39, 86). All of the mutants 
showed lower activation than native Fxn (WT > I154F > W155F > W155A > W155R) 
under the same protein concentration (Figure 4-1). I154F-Fxn lost activation ability 
about 50%, 80% for W155F, 90% for W155A, and 92% for W155R. The Fxn clinical 
mutant W155R is worse than I154F to activate the cysteine desulfurase activity, which is 
consistent to the published results that W155R-Fxn exhibited more severe early-onset 
than I154F-Fxn (39, 86). In their studies, similarly expressed I154F and W155R point 
mutants display distinct disease severities and ages of onset, suggesting differences in 
Fxn functional impairment.  
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Next, the binding ability and specific activity were explored to understand if this 
activation impairment is due to weaker binding to SDU complex. Cysteine desulfurase 
activity was measured with the titration of Fxn variants in the presence of Isu2 and 
ferrous iron to obtain the needed saturated amount of Fxn variants. The enzyme kinetics 
experiments were conducted with a titration of Fxn variants within saturated amount. 
The binding constant Kd for Fxn variant to SDU complex was calculated by fitting kcat 
over Fxn concentrations into type II allosteric activation equation 4.1. Type II allosteric 
activation is described as the value of kcat changes from a finite low value to a higher 
value, which is consistent to our results that Nfs1 still shows activity in the absence of  
 
 
FIGURE 4-1: Fxn variants loss ability to stimulate cysteine desulfurase activity. Rates of SD sulfide 
production were determined in the presence of 3 equiv of Fxn variants, 3 equiv of Isu2, and 10 equiv 
of ferrous iron. Error bar are for three independent measurements. 
 75 
 
 
Fxn (activator) (141). The kcat and KM for saturated amount of Fxn variants were 
calculated by fitting to Michaellis–Menten equation. The binding ability for Fxn variants 
to SDU complex with Ferrous iron decreased 3-fold for I154F, 30-fold for W155R and 
W155A, and 8-fold for W155F (Table 4-1). These data suggest W155R and W155A 
bind much weaker to SDU complex than WT-, I154F-, and W155F-Fxn. By comparing 
the kcat, KM and kcat/KM parameters, kcat slightly decreased from 8.5 to 6.6 min-1 and 
kcat/km decreased about 2-fold for I154F-Fxn mutant. For W155F and W155A mutants, 
both kcat and kcat/KM decreased about 2-fold. The most significant change among these 
mutants is W155R mutant, both kcat and kcat/KM greatly decreased about 5-fold. Since the 
rate-limiting step for cysteine desulfurase is persulfide cleavage/transfer step (45), the 
decreases in kcat would suggest Fxn clinical mutants, especially for W155R mutant, loss 
the ability to activate the sulfur transfer.  
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 Fxn Variants Decrease Fe–S Cluster Assembly Rate. Fe–S cluster assembly rate 
was determined by monitoring the increase in absorbance at 456 nm, commonly used for 
[Fe2S2] cluster formation (117). An assay containing SD, 3 equiv Isu2, and 3 equiv wt-
Fxn showed the specific activity of 0.49 unit/mg Isu2 (Figure 4-2 and Table 4-2). The 
Fe–S cluster formation rate for I154F, W155F, W155A, and W155R Fxn mutant are 
61%, 26%, 15%, and 7% of control wt-Fxn, which shows the same trend as the 
activation activity for cysteine desulfurase (Figure 4-1). The Fe–S cluster formation for 
W155R is almost the same as SDU complex itself (5% of control) (Table 4-2), which 
implies that W155R weakly binds SDU complex and loses the activation ability. The 
rate of Fe–S cluster formation for W155A-Fxn is 2-fold higher than W155R, but the 
  
 
 
 
FIGURE 4-2: Fe–S cluster formation kinetics with Fxn variants. Assay contained 8 µM SD, 24 µM 
Isu2, 100 µM cys, 200 µM Fe2+, 5 mM DTT, and 24 µM Fxn variants. 
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binding constant is similar (Figure 4-1), which suggests positive charged arginine 
residue (W155R) inhibits activation even more. Together, the results suggest Fxn 
variants loss the ability to assembly Fe–S cluster and W155-Fxn residue is critical for 
Fe–S cluster formation. 
 Comparison of Crystal Structures of WT, W155R, and W155A-Fxn. To 
understand the impact of W155-Fxn mutants on Fe–S cluster biosynthesis, WT, W155R, 
and W155A-Fxn crystal structures were determined at 1.30, 1.31, and 1.50 Å resolution, 
respectively, using SSRL and APS synchrotron facilities. Both wt and W155R-Fxn 
structures are in P212121 space group, and W155A-Fxn structure is in C2 space group 
(Table 4-3). Human wt-Fxn crystal structure was previously published at 1.80 Å 
resolution in year 2000 (143). Higher resolution of wt-Fxn crystal structure was provided
  
Table 4-2: Fe–S Cluster Formation Rate with Fxn Variants 
complex U/mg Isu2 Nfs1 activity 
SDU 0.025 ± 0.004 0.65 ± 0.02 
SDU + Fxn 0.490 ± 0.015 8.25 ± 0.90 
SDU + I154F 0.300 ± 0.020 4.14 ± 0.20 
SDU + W155F 0.130 ± 0.005 2.09 ± 0.51 
SDU + W155A 0.075 ± 0.005 0.83  ± 0.28 
SDU + W155R 0.035 ± 0.003 0.60 ± 0.07 
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Table 4-3: X-ray Data Collection and Refinement Statistics 
Fxn Variants Wild-type W155R W155A 
Data Collection  SSRL BL7-1 SSRL BL7-1 APS BL23-ID-D 
Wavelength (Å) 0.97945 0.97945 1.03315 
Space Group P212121 P212121 C2 
Unit cell (Å and °) 42.9, 44.8, 69.0 
90o, 90o, 90o 
38.9, 49.2, 67.1 
90o, 90o, 90o 
87.5, 32.3, 44.8 90o, 
91.4o, 90o 
Resolution (Å) 44.86-1.30 39.68-1.31 44.797-1.50 
Outer shell (Å) 1.37-1.30 1.38-1.31 1.58-1.50 
Observations 258690 476216 147672 
Unique Observations 33576 31647 20101 
Redundancy 7.7 15.0 7.3 
Completeness (%)* 100.0 (100.0) 99.8 (99.7) 99.3 (98.6) 
Mean I/(σI)* 14 (2.6) 22.2 (5.6) 12.0 (6.6) 
Rsym (%)*† 8.2 (62.4) 6.4 (41.3) 13.8 (48.3) 
Refinement    
Residues not in model 82-88, 210 82-87, 209-210 82-89 
Solvent atoms 201 169 101 
Ligand  Mg SO4 
Rwork/Rfree (%)‡ 15.3/18.7 15.1/19.7 16.9/19.2 
r.m.s.d. bond lengths (Å) 0.032 0.023 0.029 
r.m.s.d. bond angles (°) 2.7 1.8 2.6 
Ramachandran (%)    
Most favored 93.4 93.4 91.5 
Additional allowed  6.6 6.6 8.5 
Generous 0 0 0 
Disallowed 0 0 0 
PDB code 2XXX 2XXX 2XXX 
*Values in parentheses are the statistics for the highest resolution shell of data 
†Rsym = S | Ihkl - <I> | / S <I>, where <I> is the average individual measurement of Ihkl. 
‡Rwork = (S |Fobs-Fcalc|) / S|Fobs| , where Fobs and Fcalc are the observed and calculated  
structure factors, respectively. Rfree is calculated the same as Rwork, but from the data  
(5%) that were excluded from the refinement. 
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at 1.30 Å resolution here. Applying anisotropic thermal factor refinement to wt and 
W155R- Fxn, the wt-Fxn structure showed several rotamers on “acidic patch” α1 helix 
and β1 sheet (Figure 4-3), but not in W155R-Fxn structure. These carboxylate residues 
(Asp or Glu) were previously suggested as putative iron binding site (144-146). The 
different orientations of carboxylate side chain on W155R and W155A structures might 
impact on binding to iron or Fxn protein partners. The electrostatic surfaces of native 
and Fxn variant crystal structures without minor rotamers were compared. There are 
only slightly changes on acidic patch near α1 and β1 regions (Figure 4-4A), and some 
positive residues (Lys and Arg) re-orientated to different positions (Figure 4-4B). By 
looking into W155 mutation site, the loop between β3 and β4 is shifted due to the empty 
pocket on W155 position and loss of H-bonding between N148 and Q151 (Figure 4-5). 
  
 
 
 
FIGURE 4-3: Comparison of acidic regions on Fxn variant structures. wt (yellow); W155R (green); 
and W155A-Fxn (cyan). 
 80 
 
 
WT and Fxn variant structures were aligned and the residues near W155 
mutation site were compared (Figure 4-6). The loop between β3 and β4 has a significant 
3 Å movement on W155R-Fxn structure and only about 1 Å shift on W155A-Fxn 
structure by comparing wt-Fxn structure. For W155A mutant, there are some residues 
(T149–N151 and R165) slightly shift comparing to wt-Fxn structure. Surprisingly, the 
mutation W155R perturbed the surrounding residues (Q148–Q153 and R165) 
significantly. W155R lost the H-bonding with Q153, which caused the shifting of Q148 
toward the W155 mutation site and further lost H-bonding between Q148 and N151. 
R165 moved toward W155R mutation that created a weak H-bonding with Q148. These
  
(A) 
 
(B) 
 
 
FIGURE 4-4: Comparison of the electrostatic surfaces of wt (yellow), W155R (green), and W155A 
(cyan). (A) acidic patch (α1 and β1). (B) W155 mutation site on β4. 
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significant movements might be due to the loss of H-bonding interactions between 
W155 and Q153 and between Q148 and N151, and cation-π interactions (79) between 
W155 and R165. Unfortunately, I154F-Fxn is difficult to be crystallized and the 
diffraction for W155F-Fxn was poor so that the structure cannot be determined yet. 
 
 
FIGURE 4-5: The 2Fo-Fc electron density map in the W155 region of Fxn variants. Electron density is 
contoured at 2σ. (A) wt (B) W155R (C) W155A (D) Structure alignment. Color coding of oxygen red 
and nitrogen blue. 
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However, by comparing the kinetic results and structure alignment of wt-Fxn with 
W155R and W155A-Fxn, we can predict the structure of W155F would be very similar 
to wt-Fxn and the loop between β3 and β4 has less movement than W155A-Fxn.  
 
 
 
 
 
 
FIGURE 4-6: Stereo-view of structure alignment of conserved β-sheets on wt (yellow), W155R 
(green), and W155A-Fxn (cyan). 
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DISCUSSION 
 Here Fxn variants were characterized by comparing their allosteric activation 
ability for cysteine desulfurase activity, binding ability to form SDUF complex, Fe–S 
cluster formation rate, and structural dissimilarity. First, the cysteine desulfurase activity 
were measured under physiological 100 µM cysteine concentration and compared under 
the same level of protein concentration (Figure 4-1). The results showed I154F and 
W155R lost 50% and 92% activation activity, respectively, compared to wt-Fxn. These 
results can explain why W155R FRDA patient had more severe phenotype than I154F 
under the same expression level (86). The I154F and W155R variants are reported to 
have decreased thermodynamic stability (85), and diminished binding to Isd11 (110) and 
Isu1 (equivalent of human Isu2) (88). To test whether the loss of activation ability is due 
to the impairment of SDUF complex formation. Their binding ability to form SDUF 
complex were compared by titrating Fxn variants and monitoring H2S formation (see 
experimental procedures). I154F bound 3-fold weaker than wt-Fxn and, more 
significantly, W155R decreased the binding ability about 30-fold than wt-Fxn (Table 4-
1). Under the condition with the saturated amount of Fxn variant, I154F activation 
ability increased to 6.6 min-1 for kcat and 4,400 M-1s-1 for kcat/KM compared to kcat 8.5 
min-1 and 10,100 kcat/KM for wt-Fxn, but W155R only increased to 1.8 min-1 for kcat and 
2,300 M-1s-1 for kcat/KM (Table 4-1). It has been reported that the expression level of 
I154F and W155R-fxn point mutations are only about 18% of wt-Fxn level from FRDA 
patients (86), which result the deficiency of Fe-S cluster biosynthesis. Incorporation of 
I154F into a mouse cellular model system results in a FRDA like phenotype that 
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included the loss of iron-sulfur cluster enzyme activity (140). Surprisingly, functional 
analysis of the E. coli W61R (equivalent of human W155R) indicates enhanced activity 
compared to native Fxn (80). It is difficult to reconcile the decreased iron-sulfur cluster 
activity in the mouse model system and enhanced iron-sulfur cluster activity in the 
bacterial system for FRDA clinical variants. In our Fe–S cluster formation studies, I154 
and W155R depress the Fe–S cluster formation rate to 61% and 7% of control, 
respectively (Figure 4-2). Together, both I154F and W155R lose the allosteric activation 
ability due to low expression level and weaker binding ability. Specifically for W155R 
Fxn mutant, the activation activity cannot be rescued even under saturated amount 
protein concentration. It also suggests that W155R-Fxn loses activation ability might be 
contributed from structure differences to wt-Fxn. 
 The first FRDA mutant W155R crystal structure was determined at 1.31 Å 
resolution and compared with wt-Fxn and W155A-Fxn crystal structures (Table 4-2 and 
Figure 4-5). The loop between β3 and β4 along with R165 residue were rearranged in 
W155R structure (Figure 4-6). The studies from Foury’s group suggested that the spatial 
relationship on residues Q129, W131, and R141 in yeast Fxn (equivalent of human Fxn 
residues Q148, W155, and R165) is important for protein function (88). In their studies, 
W131A mutation strongly decreases the interaction with Isu1, which is consistent to our 
result that W155A has weaker binding ability to SDU complex (Table 4-1), possibly to 
Isu2. The binding constant for W155R, W155A, and W155F is 6.7, 6.1, and 1.8 µM, 
respectively. Compared to the binding constant of wt-Fxn (0.2 µM), the results suggest 
W155 is important for the binding to SDU complex to activate the cysteine desulfurase 
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activity and sulfide production. Phenylalanine residue (W155F) can partial rescue the 
binding and activation suggests the importance of the aromatic ring on residue 155 of 
Fxn.  
To further understand the interaction of Fxn with Isu2, the subunit A of A. 
aeolicus IscU (equivalent of human Isu2) crystal structure (58) was aligned with E. coli 
IscS-IscU complex structure (44) (Figure 3-4B). The structure alignment of human Isu2 
and A. aeolicus IscU hints that the C-terminal helix, which contains one of the conserved 
cysteine residues (C104, human sequence number), could possibly switch between helix 
and coil conformation. The coil conformation of the C-terminal region of Isu2 may 
expose H103 and K101 residues in order to put the C104 in the proper position to accept 
the sulfide from catalytic cysteine loop on Nfs1 (Figure 3-4B). W155 is in the right 
position to interact with K101 and H103 residues through cation-π or π-π interactions 
(79). Therefore, a working model for Fxn activation was proposed (Figure 4-7). Fxn 
binds Isu2 and SD, residue W155 on Fxn stabilizes coil conformation via the interaction 
with K101 and H103 on Isu2. This stabilization allows sulfur transfer from Nfs1 to C104 
residue on Isu2. K101 and H103 residues can “hug” W155 residue only if W155 is 
standing straight, which means Q148 and R165 residues on Fxn play important role to 
keep W155 standing still. Any perturbation from other surrounding residues would mess 
up the position of W155 residue. This model can explain why W155R and W155A have 
the similar weak binding ability. Mutation of W155F showed stronger binding ability 
than W155A and W155R that also supports the idea of cation-π interaction. But the
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reason that W155F has weaker binding than wt-Fxn is because phenylalanine only has 
one aromatic ring, which is not enough to reach the proper position to interact with K101 
and H103 residues on Isu2. Based on our model, the interactions of other known FRDA 
clinical mutants such as N146K, Q148R, and R165C with Isu2 can be predicted. N146K 
and Q148R point mutation would create the positive repulsion interactions to K101 and 
H103 that would result weak binding of Fxn to Isu2. R165C mutation would lose its 
duty to keep W155 residue in the proper position, which would also weaken the Fxn–
Isu2 interaction. Together, structure comparison of wt, W155A, and W155R-Fxn 
coupled with in vitro functional studies showed W155 is critical for Fxn and Isu2 
interaction and the residue rearrangement between β3 and β4 on Fxn further impair the 
sulfide transfer and Fe-S cluster formation. 
 
 
FIGURE 4-7: Proposed model for the activation of SDU complex by Fxn. W155 residue is required to 
induce the conformational change on C-terminal helix of Isu2 and possibly stabilized by K101 and 
H103 via cation-π or π-π interactions. The induced coil conformation on Isu2 positions C104 for 
sulfide transfer from catalytic cysteine328 on Nfs1. The persulfide bound Isu2 can be cleaved by 
DTT or form Fe–S cluster. Note, catalytic cysteine loop on Nfs1 may also have conformational 
change upon Fxn binding. 
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CHAPTER V 
STRUCTURAL ANALYSIS OF FE-S CLUSTER ASSEMBLY COMPONENTS 
 
INTRODUCTION 
 A network of protein–protein interactions appears to be critical for Fe–S cluster 
biosynthesis (13, 109). Fxn, Isu, and Nfs1 physically interact in pull-down experiments 
using yeast (108) and human (110) mitochondrial extracts. Iron-dependent Fxn-Isu 
interactions are further supported by genetic studies in yeast (111) and biophysical 
experiments with recombinant human proteins (16). Isu–Nfs1 interactions are defined by 
a crystal structure of the homologous E. coli IscU–IscS complex (44) (Figure 1-11). In 
eukaryotes, an additional protein, Isd11, is also known to form a complex with Nfs1 and 
is vital for Nfs1 functions (49, 50, 112). Fxn interacts with Isd11 has also been supported 
by pull-down experiments using human cell extract (110). Depletion of genes encoding 
Nfs1, Isd11, Isu, or Fxn in S. cerevisiae produces similar phenotypes that include defects 
in Fe–S cluster proteins (50, 113). These data hint a multiprotein complex that functions 
as a Fe–S cluster assembly machine. 
 Crystal structure of E. coli IscS-IscU complex is the only known structure for 
protein-protein interaction. Little has known about how frataxin interacts with Isu2 , 
Nfs1, and Isd11. Therefore, the need for obtaining the structural information will help to 
understand the protein-protein interactions in molecular levels. Here we are using low-
resolution structural techniques such as small-angle x-ray scattering and electron 
microscopy to determine the protein shape of each component and SDUF protein 
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complex coupled with high-resolution protein crystallography technique to determine 
Nfs1/Isd11 complex. In addition, protein docking was used to provide the initial idea for 
understanding how Fxn interacts with Nfs1 and Isu2.  
 
EXPERIMENTAL PROCEDURES 
 The Shape Determination of Fe-S Cluster Components Using Small-Angle X-Ray 
Scattering (SAXS). Human Isu2, m82–Fxn (82-210 aa.), m56–Fxn (56-210 a.a.) were 
dialyzed against 50 mM Tris pH 7.5 and 150 mM NaCl. The resulting buffer was used 
for buffer subtraction in the SAXS experiments. The samples were shipped to Stanford 
Synchrotron Radiation Laboratory (SSRL) in California under 4~10 oC sealed styrofoam 
box. A series of concentrations (1.25, 2.5, 5, 10 mg/mL for Fxn; 2.5, 5, 7.5, 8.75 mg/mL 
for Isu2) were used to evaluate the concentration-dependent aggregation or interparticle 
interference (2). 20 µL of each protein sample was injected into flow cell on Beamline 4-
2 at SSRL. The sample to detector distance is 2.5 m; beam energy is about 11 keV; and 
the exposure time is 5 sec for buffer and sample. Total 10 measurements were taken to 
evaluate radiation damage. The scattering curve, I(q), was obtained from the subtraction 
of the buffer from the sample. The data was processed by Atsas 2.2 suite (19). Each 
sample with different concentration was scaled, merged and analyzed using Primus 
program. The radius of gyration RG and absolute Intensity I(0) were extrapolated by 
Guinier approximation logI(q) vs. q using the criteria qRG ≤1.3 for globular proteins. I(0) 
was used for estimating the molecular mass of protein by comparing I(0) with the 
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molecular mass standards A206K-GFP (25 kDa), A206C-GFP (51 kDa), and RFP (104 
kDa) using equation 5.1. 
 
€ 
Mc = I(0) NA
υΔρ2
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟ ≅1.468I(0)       (5.1) 
 
M is molecular mass of protein; c is the concentration of protein in mg/mL; I(0) is the 
absolute intensity extrapolated to q = 0; NA is Avogadro constant; ν is partial specific 
volume of protein; and ∆ρ is X-ray constant. The scattering data was indirect Fourier 
transform to pair-distribution function P(r) by using Gnom program to estimate 
maximum dimension (r) of the protein.  The output file was used for ab-initio SAXS 
envelope reconstruction using GASBOR program. 10 GASBOR models were generated 
and averaged to get the final averaged SAXS model. The SAXS models were 
superimposed with known crystal structures (PDB: 1EKG for Fxn; 1WFZ for Isu2). 
Experimental SAXS scattering curves also compared with calculated SAXS scattering 
curve from known crystal structures using CRYSOL program. IscU dimer docking 
model was generated with ClusPro server using mouse NMR structure (1WFZ). The top 
ten models were converted to scattering curve using CRYSOL program. The best fit 
based on χ2 was used to superimpose into human Isu2 experimental SAXS model.  
 Determination of Isu2 Oligomeric States Using Analytical Ultracentrifugation 
(AUC). Human Isu2 protein (30 mg/mL, 0.4 mL) with 10 mM DTT was dialyzed against 
0.5 L (x2) of 10 mM sodium phosphate buffer pH 7.4 and 50 mM NaCl in the anaerobic 
glove box. The Isu2 protein was then diluted to OD280 of 0.3, 0.6, and 0.9. The 0.5 mL of 
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each samples were sent to Dr. Demeler in the Center for Analytical Ultracentrifugation 
of Macromolecular Assemblies (CAUMA) at the University of Texas Health Science 
Center at San Antonio in Texas. Sedimentation velocity data were analyzed with the 
ULTRASCAN software. The samples were centrifuged at 20 oC in 60,000 rpm using 
standard Epon two-channel centerpieces. Velocity measurements were taken at 281 nm 
using the buffer as the same as dialysis buffer and hydrodynamic corrections for buffer 
density, viscosity, and partial specific volume were applied as implemented in 
ULTRASCAN . The partial specific volume was determined to be 0.7444 cm3/g for 
Isu2. All data were analyzed by two-dimensional spectrum analysis, van Holde-
Weischet analysis, and finite element analysis (28, 29, 52). 
Crystallization of SD Complex. 1 uL of SD protein (10 mg/mL in 50 mM Tris pH 
8.0, 250 mM NaCl) with 5 mM TCEP was mixed with 1 uL of Hampton Research sparse 
matrix screening solution using Phoenix crystallization robot in the Dr. Sacchettini’s lab. 
The trays were incubated at 22 oC. After 2 weeks, yellow crystals were found in 
PEG/ION 2 # 39 crystallization condition with 20% PEG3350 and 0.04 M citric 
acid/0.06 M bis-tris propane (CBTP) pH 6.4. The crystallization conditions were 
optimized using additive screening from Hampton Research. The crystal grew to size 0.5 
mm x 0.5 mm x 0.5 mm with the additive #40 (hexammine cobalt chloride) after 2 
weeks at 22 oC in the crystallization condition 4% PEG3350 and 0.04M/0.06M CBTP 
pH 6.4. Other additives, such as LiCl, NaCl, NaI, CsCl, non-detergent NDSB-201, and 
NDSB-211, were also found to have beautiful crystals about 0.3 mm size. The crystals 
were transferred to different cryo-protecting solution, such as 25–35% ethylene glycol, 
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25–35% glycerol, 100% paratone, 35% MPD, 25% sucrose, 30% DMSO, 35–35% 
PEG400, 1.5 M NaCl, and 1M Sodium Malonate pH 7, and flash frozen in liquid 
nitrogen. The crystals were screened on Beamline 7-1 at SSRL. The crystal diffracted at 
a resolution of 6.9 Å with either 30% ethylene glycol or 30% glycerol cryo-protecting 
solution. The diffraction data were analyzed using Phenix and CCP4 suites.  
Electron Microscopy (EM) for SDUF Complex. The SDUF complex was 
prepared by incubating SD (100 µM), Isu2 (250 µM), Fxn (250 µM), and DTT (10 mM) 
in the buffer 100 mM HEPES pH 7.5 and 150 mM NaCl for 30 min in the glove box. 
The reaction was loaded on S200 analytical gel filtration column and run with the buffer 
50 mM HEPES, pH 7.5 and 150 mM NaCl. The fraction contains SDUF complex was 
diluted to 0.05 mg/mL and sent to Dr. Holzenburg at the Microscopy and Imaging 
Center at TAMU. 100 µL of protein sample was deposited on the carbon-coated grid, 
after one minute for blotted dry, then covered with a small drop of the 2% uranyl acetate 
stain. After a few seconds to allow this drop to be blotted dry, the sample is ready for 
negative stain microscopy. Since SDUF complex is a small complex about 180 kDa for 
EM, the negative stain EM is better than cryo-EM due to its high contrast property. Data 
was divided and averaged to different classes with 3485 particles and then calculated 
after multi-reference alignment using initial, reference-free classes as references. The 
final class was averaged and re-projected by applying to 2-fold symmetry to reconstruct 
3D EM model using rendering threshold of 8.0. The resolution was calculated about 24 
Å. 
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 Protein Docking for Fxn to IscS-IscU Crystal Structure. Human version of Nfs1-
Isu2 complex was built based on E. coli IscS-IscU structure (PDB: 3LVL) using SWISS-
MODEL server. The E. coli IscS-IscU complex was modified and energy-minimized 
based on human Nfs1 and Isu2 sequences. Human Fxn (Ligand) was docked to E. coli 
IscS-IscU crystal structure (Receptor) (PDB: 3LVL) using ClusPro protein docking 
server (http://cluspro.bu.edu) (65, 66). The protein complex was predicted without 
selecting any constraints. The initial structures from PIPER (69), an FFT-based rigid 
body docking program, were selected using shape complementarity, an approximation of 
the van der Waals contact energy, desolvation, and electrostatics. The top 1000 
energetically favorable structures were then clustered on the basis of a pairwise binding 
site root mean squared deviation (RMSD) criterion. Clusters were formed by selecting 
the ligand that has the most neighbors below 10Å. Each member within the cluster was 
then eliminated from the matrix to avoid overlaps between clusters. This is repeated until 
at least 30 clusters were formed. The ligand with the most neighbors is the cluster center. 
The top cluster centers are then minimized in the presence of the receptor, and 
concatenated into PDB format. The model with lowest free energy and the most 
neighbors is selected as our docking model. 
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RESULTS 
 N-Terminal Region of Human Fxn Shows a Long Disordered Tail. To understand 
why human Fxn56-210 can form oligomer, but mature Fxn82-210 cannot. Low-resolution 
small-angle x-ray scattering (SAXS) experiments were performed at SSRL beamline 4-
2. The SAXS data of Fxn56-210 and Fxn82-210 were compared. The RG and Dmax for Fxn82-
210 and Fxn56-210 are 15.4 Å and 49 Å, and 20.0 Å and 67 Å, respectively (Figure 5-1). 
The SAXS model of Fxn56-210 shows a long extra tail by comparing to Fxn82-210. This 
extra tail is corresponding to extra N-terminal region (residues 56-81). Fxn (Fxn56-210) 
has extra 27 residues on N-terminal region and the length of this N-terminal tail is about 
18 Å, which is possibly a disorder coil. This disordered N-terminal tail can be readily 
cleaved to become mature Fxn (Fxn82-210), which is consistent with previous in vivo 
observations by Puccio’s group (65). 
 
 
 
FIGURE 5-1: Docking Fxn crystal structure into ab initio SAXS model. Fxn crystal structure (cyan). 
(Left) Fxn82-210. RG = 15.4 Å, Dmax = 49 Å; (right) Fxn56-210. RG = 20.0 Å, Dmax = 67 Å.  
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 Human Isu2 Behaves in Concentration-dependent Monomer–dimer Equilibrium. 
Oligomeric state of bacterial NifU/IscU/SufU has been shown to function as a dimer (60, 
89, 147, 148). A. vinelandii IscU could bind [Fe2S2] cluster in its dimer interface and 
sequentially assemble [Fe4S4] cluster (117). In contrast, eukaryotic human Isu2 D37A 
mutant has been suggested as a monomer that can bind [Fe2S2] cluster (59). Up to date, 
all the proposed Fe–S cluster assembly mechanisms have been using IscU dimer as a 
model (91, 149). To reconcile human Isu2 oligomeric state, the small-angle x-ray 
scattering (SAXS) and analytical ultracentrifugation (AUC) experiments have been 
conducted. In SAXS experiment, the human Isu2 SAXS model was compared with 
NMR structures of mouse IscU monomer and dimer. The mouse IscU dimer was 
generated by docking two mouse IscU monomer structures (PDB: 1WFZ) by submitting 
to ClusPro protein docking server. The top 10 dimer models were converted to scattering 
curves and compared to human Isu2 SAXS scattering curve. The best fit gives χ2 about 
5.7 (Figure 5-2A). The calculated RG and χ2 for mouse IscU monomer are 16.4 Å and 
10.7. The calculated RG for mouse IscU dimer is 20.9 Å, which is very close to the RG 
(20.6 Å) for human Isu2 SAXS data. The SAXS results suggest human Isu2 is close to a 
dimer form, but not a monomer form. The SAXS data was further analyzed by pair-
distribution function to obtain the maximum dimension for human Isu2. The estimated 
maximum distance is 70 Å (Figure 5-2B). This data was then used to reconstruct the ab 
initio SAXS model. The reconstructed human Isu2 SAXS model was superimposed with 
best mouse IscU dimer model (Figure 5-3). Therefore, the SAXS model suggests human
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FIGURE 5-2: (A) Overlay of human Isu2 scattering curve with calculated mouse IscU dimer scattering 
curve generated by CRYSOL. (B) Pair-distribution function for human Isu2. The maximum 
dimension is estimated as 70 Å using GNOM program. 
 
 
FIGURE 5-3: Superimposition of human Isu2 SAXS model (green) with mouse IscU dimer docking 
structure (cyan). Conserved cysteine residues (magenta). (A) side view (B) top view. 
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Isu2 is a dimer in the solution at the protein concentration greater than 2.5 mg/mL.  
The oligomeric state of Isu2 was also investigated by using AUC. The protein 
was reduced with DTT in the anaerobic glove box and then dialyzed to remove DTT. 
The results shown here are the human Isu2 from low (OD280 of 0.3, 0.5 mg/mL) to high 
concentration (OD280 of 0.9, 1.5 mg/mL) in van Holde-Weischet distribution plot (Figure 
5-4). Plots of boundary fraction versus S20,w (sedimentation coefficient corrected for 
water at 20 oC) will be vertical if the sample is homogeneous and will show positive 
slope if the sample is heterogeneous. The sedimentation coefficient (S value) is ~1.60, 
1.65, 1.70 for low, medium, and high concentration Isu2. The AUC results indicate 
 
 
FIGURE 5-4: van Holde–Weischet distribution plot of sedimentation coefficients for human Isu2. 
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human Isu2 is concentration-dependent monomer-dimer equilibrium when protein 
concentration increases above 0.5 mg/ml (34 µM). Together, AUC and SAXS results 
suggest that human Isu2 behaves as monomer-dimer equilibrium in a concentration-
dependent manner. 
 Nfs1 and Isd11 Complex Crystallizes Only under Reduced Condition. 
Crystallization trials of cysteine desulfurase Nfs1 and Isd11 complex have been setup 
using sparse-matrix methods. Three crystallization conditions were found to produce 
yellow crystals from random screening solutions. These three conditions are PEG/ION 
#5 (12% PEG3350, 0.1 M Na malonate pH 6.0), PEG/ION #27 (12% PEG3350, 0.1 M 
Na formate pH 7.0), and PEG/ION #39 (20% PEG3350, 0.04/0.06 M CBTP pH 6.4). 
Only PEG/ION #39 can be reproduced in optimization solution, but in lower precipitant 
percentage (2–6% PEG3350). In the 2% PEG3350, 0.04/0.06 M CBTP pH 6.4 condition, 
the hanging-drop was setup and incubated at 22 oC. Two to four big yellow crystals (size 
about 0.4~0.5 mm) grew after 5 days (Figure 5-5A). The crystals were optimized and 
sent to SSRL for data collection. The crystals diffracted poorly, the best resolution was 
about 6.9 Å (Figure 5-5B). The reasons for poor diffraction might be due to improper 
cryo-protecting solution, protein degraded or oxidized, or loosely crystal packing. The 
crystallization condition was optimized with additive screening in order to get better 
quality of crystals. Different cryo-protecting solutions were also tested to minimize 
osmotic shock. The resolution of crystal diffraction was not improved. The fact that 
crystals only grew in the presence of TCEP indicates Nfs1-Isd11 complex tends to be
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oxidized and forms heterogenerous oligomer. Crystallization was then setup at 16 °C 
anaerobically. Only small crystals grew due to the vibration of the glove box when 
compressor turned on and off. The crystals were tested at SSRL and the results were 
depressing. Therefore, new condition or higher purity of protein will be tried to get 
higher quality of SD crystals. The 6.9 Å diffraction data was collected and analyzed. The 
results showed one molecule per asymmetric unit with the unit cell dimension 145.02 Å 
x 145.02 Å x 167.18 Å, 90o x 90o x 90o. The space group was indexed as P422 and the 
estimated molecule weight was 160 kDa. 
 Shape Determination of SDUF Complex Using Electron Microscopy. SDUF 
complex has been isolated using gel filtration chromatography. The low-resolution 
structure of SDUF complex was obtained using electron microscopy (EM). Over 3000
  
(A)         (B) 
 
 
FIGURE 5-5: (A) Nfs1/Isd11 crystal. (B) Diffraction image of Nfs1/Isd11 at 6.9 Å. 
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FIGURE 5-6: Averaged and classed single particle of SDUF complex using negative-stain electron 
microscopy. 
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single particles were picked, classed, and averaged (Figure 5-6). The EM model was 
reconstructed after fit with multi-reference initial model. The EM structure reveals the 
overall shape of SDUF complex in a resolution of 24 Å (Figure 5-7). The 3D-
reconstructed EM Structure has two-fold symmetry with the cavity in the center of the 
structure. The dimension of EM model is 110 Å x 80 Å x 100 Å. The width of EM 
complex is about 80 Å, which is relatively close to the width of 76 Å of E.coli IscS 
structure (PDB: 1P3W). Docking the known E. coli IscS-IscU complex (PDB: 3LVL) 
into the EM model seems not possible without changing the complex conformation. 
Notably, the structure of Isd11 is not known. It may be possible that Isd11 modifies the 
Nfs1 structure in some way. 
  
 
 
 
FIGURE 5-7: Reconstruction of EM model on SDUF complex at 24 Å resolution. 
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Fxn Protein Docking onto IscS-IscU Complex. To better understand the 
interaction of Fxn with Nfs1 and Isu2. Human Fxn was docked into E. coli IscS-IscU 
crystal structure (PDB: 3LVL) with human Nfs1 and Isu2 sequence modifications. The 
SUF complex docking model reveals Fxn structure docks into the pocket between IscS 
and IscU. The conserved β-sheets of Fxn face towards to IscU (equivalent of human 
Isu2) and the loop between β3 and β4 sheets is near the catalytic cysteine loop of IscS 
(equivalent of human Nfs1) (Figure 5-8A). W155 residue is close to IscU structure near 
C-terminal region. N-terminal acidic patch of Fxn interacts with the other subunit of 
IscS, which has many positive charge arginine residues. Structure alignment of A. 
aeolicus IscU to E. coli IscU reveals different conformations on C-terminal region 
(Figure 5-8B). The coil conformation of A. aeolicus IscU shows K101 and H103 
 
 
FIGURE 5-8: (A) Docking model of human Fxn with E. coli IscS-IscU complex (PDB: 3LVL). Fxn 
(blue), W155-Fxn shown in stick (magenta), IscS (green), catalytic cysteine loop on IscS (orange), 
PLP shown in stick (yellow), IscU (cyan), conserved cysteine residue on IscU shown in stick. (B) 
Alignment of A. aerolicus IscU to E coli IscU. A. aeolicus IscU (pink) structure has C-terminal coil 
conformation instead of helix conformation on E. coli IscU (cyan). K101, H103, and C104 
(numbered in human Isu2) shown in stick. 
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residues are close to W155 residue on Fxn. Together, docking model predicts Fxn 
interacts with IscS on N-terminal acidic patch and interacts with IscU on conserved β-
sheets. 
 
DISCUSSION 
 The high-resolution structure of SDUF complex is not known. Low-resolution 
structures of individual protein and complex were pursued to obtain the shape 
information. Recent studies in Isaya’s group revealed full-length human Fxn (Fxn56-210) 
oligomer can stimulate Nfs1 activity (66). This result was confirmed by our kinetic 
assay. To better understand the difference of Fxn56-210 and Fxn82-210, low-resolution 
SAXS models of Fxn82-210 and Fxn56-210 were obtained to compare the non-conserved N-
terminal region. The SAXS study of Fxn56-210 shows N-terminal region is a long 
disordered tail (Figure 5-1), which may either interact with other subunits to form Fxn 
oligomer or get cleaved to become mature Fxn (Fxn82-210). Based on our previous 
studies, W155 residue on Fxn is critical to activate the Nfs1 activity (Figure 4-7). It may 
be possible that W155 residue on Fxn56-210 oligomer still exposes to interact with SDU 
complex. However, this possibility is hard to fit with our docking model (Figure 5-8A) 
that Fxn sits between Isu2 and Nfs1 since Fxn56-210 oligomer is huge (1 MDa). The other 
possibility is that Fxn subunit dissociates from Fxn56-210 oligomer and interacts with 
SDU complex. The association and dissociation mechanism for Fxn56-210 oligomer is not 
known. More studies on Fxn56-210 oligomer would be required to reconcile this dilemma.  
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The human Isu2 was suggested as a monomer and can bind [Fe2S2] cluster (59). 
We revealed Isu2 forms a four-protein complex with Nfs1, Isd11, and Fxn in a 
stoichiometry of α2β2γ2δ2 (Figure 2-6 and 2-7). The SAXS results show Isu2 forms 
dimer in the solution at a concentration of 2.5 mg/mL (170 µM) or above (Figure 5-3). 
There is no larger species has been observed at a protein concentration up to 17 mg/mL 
(1.2 mM). In contrast, the AUC results show Isu2 is a monomeric species at 0.5 mg/mL 
(34 µM) and tend to form dimer with increased concentration (Figure 5-4). The cellular 
level of the IscU protein has been estimated by immunoblotting methods to be about 40 
µM (53), which is close to monomeric Isu2 concentration (34 µM) based on AUC result 
(Figure 5-4). This would suggest Isu2 is in monomeric state inside the cell. To further 
understand how Fe–S cluster bound Isu2 transfers cluster to apo target proteins. One 
possibility is chaperones GRP75 and HSC20 facilitate the dissociation of Isu2 from 
SDUF complex and assist Isu2 to transfer cluster to apo target proteins. The other 
possibility is another apo-Isu2 forms dimer with cluster-bound Isu2 in SDUF complex 
and grabs the cluster, and then dissociates. This holo-Isu2 can further transfer cluster to 
apo target protein under the assistance of chaperones. This possibility can be supported 
by our AUC and SAXS studies that Isu2 exhibits the monomer-dimer equilibrium 
(Figure 5-3 and 5-4).  
 The molecular details of interaction of Isd11 with Nfs1 and Fxn are still a 
mystery. Isd11 is an essential protein for Fe–S biosynthesis and only exists in eukaryotes 
(51). Isd11 maintains the function and stability of Nfs1 (50) and interacts with Fxn 
(110). Nfs1-Isd11 (SD) complex was crystallized as a bright yellow crystal with PLP 
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cofactor bound (Figure 5-5A). However, the diffraction was not high enough to 
determine the structure (Figure 5-5B). SD complex has molecular weight around 150 
kDa based on S200 gel filtration chromatography (Figure 2-8), which was estimated as 
two Nfs1 and two Isd11. The sequence identity of human Nfs1 and E. coli IscS is about 
60% and IscS structure shows strong dimer interface between two subunits. We can 
conclude that Nfs1 would retain the similar shape as IscS. To combine with our complex 
docking model (Figure 5-8A), Isd11 may sit between Nfs1 and Fxn interface. Isd11 has 
14 positive arginine residues, which can interact with negative aspartate and glutamate 
residues on α1 helix of Fxn. However, the shape of this docking complex is difficult to 
fit into our EM model (Figure 5-7) unless Fxn induces SDU to different conformation.  
Protein complex docking model predicts Fxn interacts between IscS (equivalent 
of human Nfs1) and IscU (equivalent of Isu2) (Figure 5-8A). The docking model reveals 
conserved β-sheet of Fxn interacts with IscU (Figure 5-8A). The position of W155 
residue of Fxn could possibly interact with K101 and H103 residues of A. aeolicus IscU 
after helix-to-coli switch occurs (Figure 5-8B). The N-terminal acidic patch of Fxn, 
which was suggested as iron binding site (146), interacts with IscS. In docking model, 
this acidic patch may interact with positive charged arginine residues on the other 
subunit of IscS (Figure 5-8B), which could be the potential iron binding site. Our 
previous studies suggest one equivalent of ferrous iron can further stimulate the Nfs1 
activity (Figure 2-1). Cowan’s group suggests Isu2 interacts Fxn only in the presence of 
ferrous iron (144). Cortopassi’s group suggests Fxn interacts with Isd11 is Ni-dependent 
(110). Regardless the exact iron binding site, our docking model shows the possible 
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interactions between Fxn and SDU complex. W155 of Fxn binds Isu2 and stabilizes the 
coil conformation to allow C104 on Isu2 to accept sulfur transfer from Nfs1 (Table 3-1). 
Docking model also supports W155 mutation would weaken the binding affinity (Table 
4-1).  
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CHAPTER VI 
CONCLUSION 
 
 Here we re-defined the role of Fxn to involve in Fe–S cluster biosynthesis. Fxn 
forms a complex with Nfs1, Isd11, and Isu2 and acts as an allosteric activator to 
initialize sulfur transfer from Nfs1 to Isu2. Fxn stabilizes the coil conformation of Isu2 
and possibly interacts with K101 and H103 on Isu2 through conserved residue W155. 
Upon Fxn binding, the Nfs1 catalytic efficiency significantly increases from 25 to 
10,100 M-1s-1. This activity stimulation is consistent with most of the published results 
and phenotype. There are still many unanswered questions about Fe–S cluster assembly 
biosynthesis such as the details of chemical mechanism of Fe–S cluster assembly, 
protein interactions between chaperones and Isu2, cluster transfer to apo target protein 
with chaperones. The fact that W155 residue of Fxn interacts with coil conformation of 
Isu2 suggests Fxn would lose the binding affinity to Isu2 once coil conformation 
switches to helix conformation for cluster bound. It indicates Fxn may leave after cluster 
has been made on Isu2, which allows chaperones come in and transfer cluster to apo 
protein. Alternatively, another apo-Isu2 comes in and grabs the cluster from holo-Isu2 
on SDUF complex, followed by transferring to apo target protein under the assistance of 
chaperones. A larger protein complex might be also possible to become a huge Fe–S 
cluster assembly machine for Fe–S cluster biosynthesis. I hope these results could help 
other researchers further understand Fe–S cluster assembly biosynthesis. 
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APPENDIX A 
MECHANISTIC AND STRUCTURAL STUDIES OF H373Q FLAVO-
CYTOCHROME B2: EFFECTS OF MUTANTING THE ACTIVE SITE BASE* 
 
ABSTRACT 
 His373 in flavocytochrome b2 has been proposed to act as an active site base 
during the oxidation of lactate to pyruvate, most likely by removing the lactate hydroxyl 
proton. The effects of mutating this residue to glutamine have been determined to 
provide further insight into its role. The kcat and kcat/Klactate values for the mutant protein 
are 3 to 4 orders of magnitude smaller than the wild-type values, consistent with a 
critical role for H373. Similar effects are seen when the mutation is incorporated into the 
isolated flavin domain of the enzyme, narrowing the effects to lactate oxidation rather 
than subsequent electron transfers. The decrease of 3500-fold in the rate constant for 
reduction of the enzyme-bound FMN by lactate confirms this part of the reaction as that 
most effected by the mutation. The primary deuterium and solvent kinetic isotope effects 
for the mutant enzyme are significantly smaller than the wild-type values, establishing 
that bond cleavage steps are less rate-limiting in H373Q flavocytochrome b2 than in the 
wild-type enzyme. The structure of the mutant enzyme with pyruvate bound, determined 
  
____________ 
*This appendix is reprinted with permission from “Mechanistic and Structural Studies of 
H373Q Flavocytochrome b2: Effects of Mutating the Active Site Base” by Tsai, C.-L., 
Gokulan, K., Sobrado, P., Sacchettini, J.C., Fitzpatrick, P.F. (2007). Biochemistry, 46, 
7844-7851, Copyright [2007] by American Chemical Society. 
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at 2.8 Å, provides a rationale for these effects. The orientation of pyruvate in the active 
site is altered from that seen in the wild-type enzyme. In addition, the active site residues 
R289, D292, and L286 have altered positions in the mutant protein. The combination of 
an altered active site and the small kinetic isotope effects is consistent with the slowest 
step in turnover being a conformational change involving a conformation in which 
lactate is bound unproductively. 
 
INTRODUCTION 
  Flavocytochrome b2 from Saccharomyces cerevisae is a lactate dehydrogenase 
that catalyzes the transfer of a hydride equivalent from its hydroxy acid substrate to the 
enzymebound flavin and thence to proteins of the mitochondrial electron transport chain 
via a bound cytochrome (1). This enzyme is the paradigm for the flavoproteins that 
catalyze the oxidation of α-hydroxy acids, a family of enzymes with conserved three-
dimensional and active site structures found in plants, animals, and bacteria (2–8). The 
two cofactors of flavocytochrome b2 are in different domains of the protein (9). Residues 
1–99 make up the heme binding domain and resemble cytochrome b5 in structure. 
Residues 100–486 contain the FMN in a TIM barrel. This flavin domain is homologous 
to the other α-hydroxy acid-oxidizing flavoproteins (6) and can catalyze lactate 
oxidation in the absence of the heme domain (10). Figure A-1 shows the arrangements of 
amino acids in the active site of flavocytochrome b2 in relation to the FMN cofactor and 
bound pyruvate product (9). Of the seven amino acid residues in Figure A-1, six are 
conserved in all members of the family to date, whereas Y143 is conserved in most 
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FIGURE A-1: Interactions between active site residues in wild-type flavocytochrome b2 and pyruvate, on 
the basis of pdb file 1KBI (39). (39). 
 
 
FIGURE A-2: Alignment of sequences of flavoprotein hydroxy acid oxidases and dehydrogenases, 
showing conservation of active site residues. The residue numbering is for flavocytochrome b2. 
 
 
FIGURE A-3: Proposed mechanism for oxidation of lactate by flavocytochrome b2 (19). 
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(Figure A-2). Site-directed mutagenesis has confirmed the importance of several of these 
residues for substrate oxidation by this family of flavoproteins (11–21).  
The details of the mechanism by which these enzymes transfer a hydride 
equivalent from the α-hydroxy acid substrate to the flavin have been controversial (22–
24). Results of mechanistic studies have been interpreted as evidence for removal of the 
α-hydrogen both as a proton, followed by subsequent transfer of electrons, and as a 
hydride so that the proton and two electrons are simultaneously transferred to the flavin.  
A similar controversy exists for the related flavoprotein amine oxidases, for which there 
is accumulating support for a hydride transfer mechanism (24–27). Recently, deuterium 
and solvent kinetic isotope effects on wild-type flavocytochrome b2 and the Y254F 
mutant enzyme led to a variation on a mechanism involving hydride transfer (Figure A-
3) (19). In this mechanism, H373 acts as a base to remove the hydroxyl proton of the 
substrate and form an alkoxide. The α-hydrogen is then transferred to the FMN as a 
hydride. The previous results could not distinguish whether the alkoxide is a true 
intermediate or whether the reaction is highly asynchronous with proton transfer 
essentially complete in the transition state for CH bond cleavage. The role of H373 in 
this proposal is different from that in which the α-hydrogen is removed as a proton to 
form a carbanion, where this residue is the base that abstracts the α-proton (28).  
Site-directed mutagenesis of H373 in flavocytochrome b2 or of the corresponding 
residue in other members of this family of flavoproteins results in a large decrease in 
activity. In the case of flavocytochrome b2, the kcat and kcat/Km values of the mutant 
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enzyme have been reported to be 8000- and 3500-fold lower than the wild-type values 
(16). Because the Km value for lactate only changed 2- to 3-fold in the mutant protein, 
the low residual activity was attributed to contamination with wild-type enzyme, leading 
to the conclusion that the mutant enzyme is at least 10,000-fold less active than the wild-
type enzyme. In the case of lactate monooxygenase from Mycobacterium smegmatis, the 
H290Q enzyme cannot be reduced by lactate, consistent with a decrease of 7 to 8 orders 
of magnitude in activity (14). Similarly, mutation of H274 in mandelate dehydrogenase 
from Pseudomonas putida to glycine, alanine, or asparagine yields enzyme with no 
detectable activity, consistent with decreases of at least 100,000-fold (18). Decreases in 
activity of this magnitude would be unexpected for the mechanism of Figure A-3, where 
the histidine is not involved in a rate-limiting bond cleavage. Although large decreases 
in the activities of the mutant proteins would be more consistent with a mechanism in 
which the base removes a proton from carbon in a ratelimiting step, the effects are quite 
large even for such a role. Consequently, we have re-examined H373Q flavocytochrome 
b2, using a combination of kinetic and structural approaches. The results of these 
analyses are described here. 
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EXPERIMENTAL PROCEDURES 
Materials. Lithium L-lactate and D,L-lactate were from Sigma (St. Louis, MO). 
Sodium L-[2-2H]-lactate (98%) and deuterium oxide (99.9%) were purchased from 
Cambridge Isotope Co., (Andover, MA). Hydroxyapatite was from Bio-Rad 
Laboratories (Hercules, CA).  
Enzyme Preparation. Site-directed mutagenesis of H373 to glutamine was 
performed following the QuikChange protocol (Stratagene) with the primers 5’-
GGTGGTTCTATCCAATCAAGGTGGTAGACAATTAGA-3’ and 5’-TCTAATTGT-
CTACCACCTTGATTGGATAGAACCACC-3’. The H373Q mutation was introduced 
into the genes for the wild-type enzyme in pET21d and for the flavin domain in pDSb2 
(29). The expression and purification of the wild-type enzyme and mutant enzymes were 
as described previously (19, 29). Enzyme concentrations were determined using an ε423 
value of 183 mM-1 cm-1 and an ε413 value of 129.5 mM-1 cm-1 for the reduced and 
oxidized full length enzymes, respectively (30), and an ε453 value of 11.1 mM-1 cm-1 for 
the flavin domain (31). Purified enzymes were stored in 100 mM potassium phosphate, 1 
mM EDTA, and 20 mM D,L-lactate at pH 7.5, at –70 °C. To remove the lactate used for 
storage, the day of use an aliquot was precipitated with 70% ammonium sulfate in 100 
mM potassium phosphate, 1 mM EDTA at pH 7.5, at 4 °C. The pellet obtained by 
centrifugation at 15,000g for 5 min was resuspended in 100 mM potassium phosphate 
and 1 mM EDTA at pH 7.5. This procedure was repeated twice. The final enzyme 
concentration was about 3 µM. This treatment also resulted in oxidation of the cofactors. 
For stopped-flow experiments, enzyme was passed through a Sephadex G-25 column in 
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100 mM potassium phosphate and 1 mM EDTA at pH 7.5 to remove the lactate.  
Enzyme Assays. Initial rate assays were performed in 100 mM potassium 
phosphate, 5 mM EDTA, and 1 mM potassium ferricyanide at pH 7.5 and 25 °C, with 
varied concentrations of L-lactate or L-[2-2H]lactate, following the decrease in 
absorbance at 420 nm and using an ε420 value for ferricyanide of 1.04 mM-1 cm-1. For the 
flavin domain, 3 mM potassium ferricyanide was used. Concentrations of lactate were 
determined by end-point assay with wild-type flavocytochrome b2. For pH studies, the 
buffers were 50 mM Bis-Tris at pH 5.5–7.0, 150 mM HEPES at pH 7.0–8.5, and 50 mM 
ethanolamine at pH 8.5-10.0. All assays were done in the presence of 1 mM potassium 
ferricyanide at 25 °C. Solvent isotope effects were determined in 100 mM phosphate, 1 
mM EDTA at pH 7.5 or pD 8.0, with 1 mM potassium ferricyanide at 25 °C. Assays 
were initiated by the addition of 5 µL of enzyme in H2O to a final volume of 1 mL. 
 Rapid Reaction Kinetics. Rapid reaction kinetic measurements were performed 
with a Applied Photophysics SX.18MV stopped-flow spectrophotometer. Enzyme in 100 
mM potassium phosphate and 1 mM EDTA at pH 7.5 was mixed with an equal volume 
of the same buffer containing 10 mM lactate at 25 °C. Enzyme reduction was monitored 
at 438 nm. Data Analysis. Kinetic data were analyzed using the programs KaleidaGraph 
(Adelbeck Software, Reading, PA) and Igor (Wavemetrics, Lake Oswego, OR). Initial 
rate data were fit to the Michaelis-Menten equation to obtain kcat, kcat/Klactate, and Klactate 
values. Primary deuterium and solvent isotope effects were calculated using eqs A.1–
A.3. Equation A.1 describes separate isotope effects on the kcat and kcat/Klactate values; eq 
A.2 describes an isotope effect on the kcat value only; and eq A.3 describes an isotope 
 136 
effect on the kcat/Klactate value only. Here, Fi is the fraction of heavy atom substitution in 
the substrate, Ev is the isotope effect on the kcat value minus 1, and Evk is the isotope 
effect on the kcat/Klactate value minus 1. Stopped-flow traces were fit to eq A.4, which 
describes a single-exponential decay: A is the absorbance at time t, A∞ is the final 
absorbance, and k is the first-order rate constant.  
ν/e  = kcat A/[Km (1 + Fi(Evk)) + A(1 + Fi(Ek))]   (A.1) 
ν/e = kcat A/[Km + A(1 + Fi(Ev))]    (A.2) 
ν/e = kcat A/[Km(1 + F(Evk) + A]    (A.3) 
At = A∞ + Ae-kt       (A.4) 
Crystallization. Initial crystallization of H373Q flavocytochrome b2 (7 mg mL-1 
plus 50 mM pyruvate) was carried out at 18 °C by vapor diffusion with the hanging drop 
method (32) using a sparse matrix kit (Crystal Screen I and II, Hampton Research, CA). 
Well-diffracting crystals were obtained in 4–8 days at 18 °C from 4 µL hanging drops 
consisting of a 1:1 mixture of H373Q flavocytochrome b2 and a crystallization buffer 
containing 100 mM sodium citrate at pH 4.6, 17% polyethylene glycol 3000, and 0.2 
mM sucrose monolaurate.  
Data Collection. Crystals mounted in cryo loops were flash-cooled in a N2 
stream (120 K) after brief soaks in 2 µL of the mother liquor plus 2 µL of 50% glycerol. 
The data from the H373Q crystals were recorded on Advanced Photon Source beam line 
23ID using a CCD detector. The diffraction data were reduced using DENZO, and 
intensities were scaled with SCALEPACK (33). The reflections were indexed as 
primitive tetragonal (a = b = 163.68 Å, c = 112.01 Å) with Laue symmetry 3m1. 
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Examination of the integrated and scaled data indicated the trigonal space group P3221. 
Solvent content calculations (34) indicated the presence of the homodimer in the asym-
metric unit. The crystallographic data collection, statistics and refinement parameters are 
summarized in Table A-1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Structure Determination and Refinement. The three-dimensional structure of 
H373Q flavocytochrome b2 complexed with pyruvate was solved by molecular replace-
ment using EPMR (35) with the wild-type structure file 1FCB as the search model for 
the data extending from 25 to 3.5 Å. After model building and fitting, bias minimized 
electron density maps were obtained using the Shake and Warp protocol (36). The 
Table A-1: Data Collection and Refinement Statistics for 
H373Q Flavocytochrome b2 
Data collection  
resolution, Å 2.80 to 30.00 
total no. of reflections 69,254 
no. of unique reflections 36,191 
completeness 88% 
I/[(I)] 14.5 
I/[(I)] in outer shell 1.9 
R merge 0.26% 
refinement  
R-factor 0.21 
R-free 0.27 
number of protein atoms 7,077 
number of water molecules 18 
rmsd from ideal values  
bond lengths (Å) 0.005 
bond angels (deg) 2.02 
Ramachandran analysis  
most favored (%) 74% 
additionally allowed (%) 24.3% 
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refinement continued with structure factors measuring 1.0 sigma or better within the 
resolution range 30 to 2.8 Å to reduce the effects of poorly measured reflections. After 
repeated cycles of refinement and manual model building, water molecules were added 
to the structure using Xfit (37). The final model consists of two protein molecules, 
subunit A and subunit B. Subunit A contains the ordered heme domain as well as the 
flavin domain. Subunit B shows no interpretable density for the heme domain; therefore, 
it has been omitted from the model. In both subunits, no electron density was observed 
for residues 298–317, suggesting that they are highly disordered. 
 
RESULTS 
  Kinetic Characterization of H373Q Flavocytochrome b2. To determine the 
effects of mutating H373 flavocytochrome b2 to glutamine, the steady-state kinetic 
parameters of the mutant protein were determined. The results of these analyses are 
summarized in Table A-2. Ferricyanide was used as the electron acceptor because lactate 
oxidation is rate-limiting with this substrate, unlike the situation with cytochrome c as 
substrate (1). The mutant protein still has some activity as a lactate dehydrogenase, 
although there is a substantial decrease in activity compared to that of the wild-type 
enzyme. With the intact protein, the kcat/Km value for lactate is 48,000-fold lower than 
the wild-type value, while the kcat value is 12,000-fold lower. In addition, the Km values 
are altered slightly. The Km value for ferricyanide increases to 0.11 ± 0.01 mM (results 
not shown) from a reported value of less than 0.1 mM for the wild-type enzyme (38). 
The kcat and kcat/Klactate values for the mutant protein are comparable to those previously 
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reported by Gaume et al. (16) with dichlorophenol indophenol as the electron acceptor. 
The mutation does not significantly affect the Km value for cytochrome c, in that the 
mutant protein has a Kcytc value of 210 ± 42 µM compared to a value of 180 µM for the 
wild-type enzyme (1), but the kcat value of the mutant protein is only one-half as large 
with cytochrome c as the acceptor compared to the value with ferricyanide (results not 
shown).  
The complete reaction catalyzed by flavocytochrome b2 includes lactate oxida-
tion and electron-transfer steps. To determine if the effects of the mutation were due to a 
decrease in the rate constants for electron transfer from the flavin to the heme, the 
mutation was also incorporated into the isolated flavin domain of the enzyme. With this 
protein, electrons must be transferred directly from the reduced flavin to the exogenous 
electron acceptor rather than being passed through the bound cytochrome. The kinetic 
  
 
 
Table A-2: Steady-state Kinetic Parameters for Wild-type and Mutant Flavocytochrome b2 
 Intact protein  Flavin protein 
 H373Q   H373Q Kinetic 
parameter Wild-type  eq χ2  Wild-type  eq χ2 
kcat, s-1 372 ± 12 0.031 ± 0.001    200 ± 7 0.057 ± 0.001   
kcat/Klactate, 
mM-1s-1 2300 ± 220 0.048 ± 0.003    543 ± 32 0.23 ± 0.02  ± 
Klactate, mM 0.16 ± 0.02 0.65 ± 0.06    0.36 ± 0.03 0.25 ± 0.03   
Dkcat 2.9 ± 0.1 1.71 ± 0.07 B.1 0.000204  3.7 ± 0.3 1.42 ± 0.08 B.1 0.000152 
  1.78 ± 0.05 B.2 0.000208   1.47 ± 0.06 B.2 0.000158 
D(kcat/Klactate) 3.0 ± 0.3 1.16 ± 0.14 B.1   3.5 ± 0.2 1.18 ± 0.25 B.1  
  3.2 ± 0.4 B.3 0.000591   2.80 ± 0.65 B.3 0.000454 
D2Okcat 1.38 ± 0.07 0.99 ± 0.05 B.1 0.000576  1.18 ± 0.05 ndb   
  1.04 ± 0.04 B.2 0.000589      
D2O(kcat/Klactate) 0.90 ± 0.04 1.21 ± 0.16 B.1   0.44 ± 0.05 nd   
  1.18 ± 0.10 B.2 0.00578      
a Data from ref 29. b nd, not determined 
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parameters for the flavin domain of the mutant protein are slightly higher than those of 
the intact protein (Table A-2), but the kcat and kcat/Klactate values are still several thousand-
fold less than the wild-type values. Thus, the effects of the mutation are primarily in 
steps for lactate oxidation.  
As a more direct measure of the effect of the mutation on the rate constant for 
lactate oxidation, the mutant enzyme was mixed with 5 mM lactate in the stopped-flow 
spectrophotometer in the absence of an electron acceptor. The resulting spectral change 
was monophasic, with the reduction of both the flavin and the heme occurring with the 
same rate constant of 0.15 ± 0.04 s-1. This is a decrease of 3500-fold from the wild-type 
value of 520 s-1 (29). Comparable results were obtained for the isolated flavin domain, 
with a rate constant for reduction by 5 mM lactate of 0.09 ± 0.02 s-1. Thus, the effect of 
the mutation can be attributed to a substantial decrease in the rate constant for flavin 
reduction. The simultaneous reduction of both cofactors in the intact mutant protein is 
consistent with electron transfer from reduced flavin to heme being much more rapid 
than the reduction of the flavin by lactate.  
With wild-type flavocytochrome b2, there is no solvent isotope effect on lactate 
oxidation, but there is a significant primary deuterium isotope effect (29). This is 
consistent with the rapid and reversible removal of the hydroxyl proton followed by 
much slower cleavage of the carbon-hydrogen bond of lactate. If the role of H373 is to 
abstract the hydroxyl proton as shown in Figure A-3, there should be a significant 
solvent isotope effect in the mutant protein as this step becomes rate-limiting; the 
magnitude of the primary isotope effect may also be altered, depending on the relative 
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magnitudes of the rate constants for OH and CH bond cleavage. Consequently, primary 
and solvent isotope effects were determined for H373Q flavocytochrome b2. Primary 
deuterium isotope effects were determined for both the intact mutant protein and for the 
flavin domain. In both cases, there was a slightly better fit of the data to eq A.1, which 
applies for significant and nonidentical isotope effects on both the kcat and the kcat/Klactate 
values, than to either eq A.2, which describes an effect on kcat only, or eq A.3, which 
describes an effect on kcat/Klactate only. The resulting isotope effects on the kcat values are 
significantly smaller than the effects seen for the wild-type enzyme but still substantially 
greater than unity. The primary isotope effect on the kcat/Klactate value is also significantly 
smaller than the wild-type value. For both the intact protein and the flavin domain, the 
D(kcat/Klactate) value is statistically only marginally greater than unity. However, when the 
data are analyzed using eq A.2, which applies when there is only an isotope effect on the 
kcat value, the resulting χ2 values are slightly larger than is the case with eq A.1.  
Prior to measurement of the solvent isotope effects, the pH dependence of the kcat 
and kcat/Klactate values of the mutant protein were determined. Both kinetic parameters are 
independent of pH over the pH range 5.5-10 (results not shown). Solvent isotope effects 
were then determined at pH 7. With wild-type flavocytochrome b2, there is a small 
solvent isotope effect on the kcat value due to effects on the oxidative half-reaction and a 
slightly inverse effect on the kcat/Klactate value, attributed to a conformational change (29). 
In contrast, H373Q flavocytochrome b2 exhibits no significant solvent isotope effect on 
the kcat value and a very small normal effect on the kcat/Klactate value (Table A-2). Taken 
together, the isotope effects suggest that both hydrogen abstraction steps have become 
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less rate-limiting in the mutant protein.  
Structural Characterization of H373Q Flavocytochrome b2. To obtain further 
insight into the effects of the mutation on the properties of the enzyme, the crystal 
structure of H373Q flavocytochrome b2 was determined at 2.8 Å. The two subunits in 
the asymmetric unit are not equivalent in the structure of the mutant protein. The 
electron density map clearly shows the absence of the heme domain in subunit B and the 
presence of bound pyruvate at the active site of subunit B only (Figure A-4A). This 
asymmetry is also observed in structures of the wild-type enzyme (9, 39). The mutation 
of H373 to glutamine does not result in any change in the overall protein structure from 
that seen for the wild-type enzyme. The mutant protein shows the largest divergence  
 
 
 
 
 
FIGURE A-4: (A) Electron density of ligands complexed with H373Q flavocytochrome b2. The 
electron density of Snw omit maps is contoured at the 1σ level. (B and C) Comparison of the active 
sites of wild-type and H373Q flavocytochrome b2. The residues and pyruvate (PYR) with carbons in 
cyan represent the wild-type enzyme structure, whereas the carbon atoms for the mutant structure are 
in gray. The wild-type enzyme structure is from pdb file 1KBI (39). 
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from the wild-type structure for residues 292–298 and 317–324 (rmsd 1.78 and 1.70 Å, 
respectively), residues adjacent to a surface loop that is not seen in any available struc-
ture, and residues 100–114 of subunit B, which connect to the missing heme domain in 
that subunit.  
Figure A-4 compares the active site chain B of H373Q flavocytochrome b2 with 
that of the wild-type enzyme, whereas Figure A-5 illustrates the interactions between the 
active site of the mutant protein and the bound pyruvate. Omit electron density (36) 
maps of the mutant protein show clear electron density for the side chain of Gln373 in 
the mutant protein. The glutaminyl side chain of the mutant protein overlaps with the 
 
 
 
FIGURE A-5: Interactions between active site residues in H373Q flavocytochrome b2 and pyruvate. 
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side chain of H373 in the wild-type enzyme (Figure A-4B). However, the heteroatoms of 
the side chains of the glutamine in the mutant protein are twisted by 90° relative to the 
imidazole nitrogens in H373, and this results in altered interactions with D282 and 
pyruvate. In the mutant enzyme, the distance from the glutaminyl side chain to OD1 in 
D282 is comparable to the distance to the histidinyl side chain in the wild-type protein at 
2.6 Å. In contrast, the distance to OD2 in D282 has increased from 3.5 Å in the wild-
type enzyme to 4.1 Å in the mutant protein due to the different relative positions of the 
heteroatoms in the histidinyl and glutaminyl side chains (Figure A-5). In addition, in the 
wild-type enzyme, the NE2 of H373 is 2.9 Å from the carbonyl oxygen of pyruvate and 
3.2 Å from one of the pyruvate carboxylate oxygens; in the mutant enzyme, the 
corresponding atom of the glutaminyl side chain is closer to the pyruvate carboxylate 
oxygen (2.8 Å) than the carbonyl (3.1 Å) (Figure A-1). The different positions of the 
heteroatoms involved in this interaction in the wild-type and mutant proteins shift the 
pyruvate 0.7 Å relative to its position in the wild-type enzyme. The pyruvate is also 
twisted in the mutant enzyme relative to its position in the wild-type protein so that the 
interactions of the carboxylate with R376 and Y143 are altered, even though the 
positions of these residues are not (Figure A-4C). In the wild-type enzyme, pyruvate 
CO1 interacts with the NE of R376, while CO2 interacts with R376 NH2 and the 
phenolic oxygen of Y143 (Figure A-1). The interaction of R376 with Y143 is only 
slightly longer in the mutant enzyme, but the distance from the pyruvate carboxylate 
CO2 to R376 has increased from 3.0 to 4.7 Å so that the primary interaction of this 
oxygen is now with Y143 (Figure A-5).  
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More dramatic changes are seen in the positions of other active site residues in 
the mutant protein, most notably R289, L286, and D292 (Figure A-4C). In the wild-type 
structure, NE of R289 is too far from the pyruvate carboxylate for an electrostatic 
interaction; in contrast, in the mutant protein, the position of the side chain of R289 has 
shifted by 2 Å so that NE of R289 is close enough (3.8 Å) to exert some electrostatic 
influence on the pyruvate carboxylate CO2. This movement of R289 also results in a 
displacement of the side chain of L286 by over 2 Å. Finally, in the wild-type structure, 
the guanidinium nitrogens of R289 are at appropriate distances (2.8 and 3.4 Å) from the 
carboxylate oxygens of D292 for ionic interactions (Figure A-1). In H373Q 
flavocytochrome b2, both NH1 and NH2 of R289 are farther from the carboxylate 
oxygens of D292, 3.4 and 5.4 Å, respectively, so that only one oxygen of D292 is close 
enough to interact (Figure A-5). As a result, the electropotential surface of the active site 
is altered so that the acidic charge of D292 is neutralized by R289 in the wild-type 
enzyme but not in the mutant protein (Figure A-6).  
Similar changes are seen in the active site of chain A, although there is no 
pyruvate in the active site in this case. The glutamine at position 373 occupies the same 
position as H373 of the wild-type enzyme, as does D282. As is the case in subunit A, the 
side chains of L286, R289, and D292 are displaced. As a result, the interactions of R289 
with both D292 and R376 are also weaker in this subunit. 
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FIGURE A-6: Eletrostatics of the substrate binding pockets of wild-type (A) and H373Q (B) flavo-
cytochrome b2 (red, -9.8 KT/e; white, neutral; and blue, +3.4 KTe). 
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DISCUSSION 
The effects of the mutation of H373 to glutamine are fully consistent with this 
residue having an important role in the flavocytochrome b2 reaction. Both the kcat and 
kcat/ Klactate values decrease by 3 to 4 orders of magnitude, in line with the expectations 
for the mutation of an active site base. The steady-state kinetic properties of the intact 
enzyme with ferricyanide as the electron acceptor agree with a previous study of this 
mutant by Gaume et al. (16). However, the additional kinetic data presented here do not 
support the previous conclusion that the residual activity seen with preparations of the 
mutant protein is due to small amounts of the wild-type enzyme produced by ribosomal 
incorporation of histidine at position 373. If that were the case, the isotope effects on the 
mutant enzyme would be identical to those on the wild-type enzyme, and the rate 
constant for flavin reduction would not show a similar decrease. Instead, the kinetic 
parameters in Table A-2 directly reflect the effects of the mutation on the enzyme. The 
kinetic data establish that mutation of H373 to glutamine primarily alters flavin 
reduction. The effects of the mutation on the intact protein are mirrored in the effects on 
the isolated flavin domain, for which the kcat value clearly does not include electron 
transfer to the heme. Even more explicitly, the decrease of 3,500-fold in the rate constant 
for flavin reduction measured in single-turnover analyses directly identifies the decrease 
in this kinetic parameter as the critical effect of the mutation.  
Although there has been substantial controversy regarding the mechanism of 
lactate oxidation by flavocytochrome b2 and the other flavoprotein hydroxy acid 
oxidases (22, 24), the mechanism shown in Figure A-3 accommodates the vast majority 
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of kinetic and structural studies to date. Here, the role of H373 is to abstract the lactate 
hydroxyl proton prior to hydride transfer; the negative charge that develops on the 
oxygen is stabilized by Y254. The effects of mutating Y254 to phenylalanine (19) 
provide a benchmark for the expected effects of mutating H373. In the Y254F enzyme, 
the rate constant for flavin reduction decreases 35-fold. More informatively, in terms of 
insight into the catalytic details, that mutant enzyme exhibits a primary deuterium 
isotope effect on kcat of 4.5 and a solvent isotope effect of 1.4, whereas there is no effect 
of D2O on flavin reduction in the wild-type enzyme (19). These results were previously 
interpreted as resulting from a change in mechanism in the mutant enzyme to a more 
synchronous cleavage of the OH and CH bonds, as the loss of the interaction stabilizing 
the alkoxide results in a delay in OH bond cleavage until hydride transfer is initiated. 
Mutagenesis of the base responsible for abstracting the lactate hydroxyl proton would be 
anticipated to qualitatively have the same effect on the reaction, in that loss of the lactate 
hydroxyl proton would not occur until the decreasing electron density at the α carbon 
due to transfer of the hydride sufficiently decreased the pKa of the oxygen for 
deprotonation to occur in the absence of the histidine. This synchronous cleavage of the 
two bonds should be reflected in solvent and primary kinetic isotope effects with values 
close to those seen with the Y254F enzyme. Indeed, this is the result upon mutagenesis 
of the histidine in choline oxidase, which abstracts the substrate hydroxyl proton prior to 
hydride transfer (40). However, the isotope effects summarized in Table A-2 do not 
agree with this prediction. The primary isotope effects on both the intact mutant protein 
and on the flavin domain are significantly smaller than the wild-type values, whereas the 
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solvent isotope effects are very close to unity.  
The isotope effects suggest that the greatest effect of the mutation is not on a 
bond cleavage step. The structure of the mutant enzyme provides an explanation for the 
altered activity. Although the glutamine occupies the same space in the mutant protein 
that the histidine does in the wild-type enzyme, the mutation has significant effects on 
the active site structure. The binding of pyruvate is altered in the mutant protein, 
suggesting that the binding of the substrate lactate is also altered. The mutation results in 
a change in the interaction between D282 and the glutamine at position 373 that is 
propagated down the polypeptide backbone such that several active site residues have 
altered positions in the mutant protein. Of the residues showing altered positions in the 
mutant protein, R289 is probably the most critical. This residue is conserved throughout 
the family of flavoproteins that oxidize α-hydroxy acids. The side chain of R289 
interacts with that of R376, the key residue for binding the carboxylate of the substrate 
(21). The conservative mutation of R289 to lysine has been described previously and 
provides a measure of the effect on activity that any change in this residue will have. The 
R289K mutation results in a decrease in the kcat value of about 30-fold and a decrease in 
the kcat/Klactate value of about 90-fold. On the basis of the structure of the mutant, the 
decrease in activity in the mutant protein was attributed to altered electrostatic 
interactions in the active site (21). The H373Q enzyme described here also shows altered 
electrostatics in the active site (Figure A-6).  
A straightforward explanation activity of the H373Q enzyme is that there are two 
contributions to the decrease in activity. The mutation of the activity site base that 
 150 
removes the hydroxyl proton would be expected to decrease the rate constant for lactate 
oxidation by 1 to 2 orders of magnitude, on the basis of the properties of the Y254F 
enzyme. The altered binding of the substrate and the altered electrostatics in the active 
site result in a further decrease in activity. However, the kinetic data are not compatible 
with the minimal model in which these changes simply result in a decreased rate 
constant for lactate oxidation. In such a case, this step would become rate-limiting, 
resulting in expression of the intrinsic isotope effects for CH and OH bond cleavage. 
Instead, the primary and solvent isotope effects are much smaller than those seen with 
the Y254F enzyme. The data can be explained by a model in which the binding mode 
seen in the structure is not the reactive form. Instead, the substrate binds to this 
unreactive form, and a conformational change is required to yield a reactive 
conformation. This introduces an internal commitment that suppresses the isotope effect. 
The rate constant for the reversal of the conformational change must be at least 10-fold 
faster than CH bond cleavage to decrease the D(kcat/Km) from the intrinsic value of 5 to 
the observed value. Similarly, the forward rate constant for the conformational change 
must be about 7-fold slower than CH bond cleavage to reduce the Dkcat value of the 
flavin domain to 1.5. H373Q flavocytochrome b2 thus provides an example of a mutation 
in which the structural effects of the mutation on catalysis are comparable to the effects 
on chemical steps. This observation raises the possibility that the larger effects of 
mutating this residue in other members of this family of flavoproteins are due primarily 
to structural perturbations. 
 
 
 151 
REFERENCES 
 
1. Lederer, F. (1991) Flavocytochrome b2, in Chemistry and Biochemistry of 
Flavoenzymes (Muller, F., Ed.) Vol. II, pp 153-242, CRC Press, Boca Raton, FL.  
2. Urban, P., Chirat, I., and Lederer, F. (1988) Rat kidney L-2-hydroxyacid oxidase. 
Structural and mechanistic comparison with flavocytochrome b2 from Baker’s 
yeast, Biochemistry 27, 7365-7371. 
3. Tsou, A. Y., Ransom, S. C., Gerlt, J. A., Buechter, D. D., Babbitt, P. C., and 
Kenyon, G. L. (1990) Mandelate pathway of Pseudomonas putida: Sequence 
relationships involving mandelate racemase, (S)-mandelate dehydrogenase, and 
benzoylformate decarboxylase and expression of benzoylformate decarboxylase 
in Escherichia coli, Biochemistry 29, 9856-9862. 
4. Ghisla, S., and Massey, V. (1991) L-Lactate Oxidase, in Chemistry and 
Biochemistry of Flavoenzymes, Vol. II (Muller, F., Ed.) pp 243-289, CRC Press, 
Boca Raton. 
5. Giegel, D. A., Williams, C. H., Jr., and Massey, V. (1990) L-Lactate 2-
monooxygenase from Mycobacterium smegmatis. Cloning, nucleotide sequence, 
and primary structure homology within an enzyme family, J. Biol. Chem. 265, 
6626-6632. 
6. Lindqvist, Y., Brändén, C.-I., Mathews, R., and Lederer, F. (1991) Spinach 
glycolate oxidase and yeast flavocytochrome b2 are structurally homologous and 
evolutionarily related enzymes with distinctly different function and flavin 
 152 
mononucleotide binding, J. Biol. Chem. 266, 3198-3207. 
7. Maeda-Yorita, K., Aki, K., Sagai, H., Misaki, H., and Massey, V. (1995) L-
Lactate oxidase and L-lactate monooxygenase: mechanistic variations on a 
common structural theme, Biochimie 77, 631-642. 
8. Cunane, L. M., Barton, J. D., Chen, Z. W., Le, K. H., Amar, D., Lederer, F., and 
Mathews, F. S. (2005) Crystal structure analysis of recombinant rat kidney long 
chain hydroxy acid oxidase, Biochemistry 44, 1521-1531. 
9. Xia, Z.-X., and Mathews, F. S. (1990) Molecular structure of flavocytochrome b2 
at 2.4 Å resolution, J. Mol. Biol. 212, 837-863. 
10. Balme, A., Brunt, C. E., Pallister, R. L., Chapman, S. K., and Reid, G. A. (1995) 
Isolation and characterization of the flavinbinding domain of flavocytochrome b2 
expressed independently in Escherichia coli, Biochem. J. 309, 601-605. 
11. Reid, G. A., White, S., Black, M. T., Lederer, F., Mathews, F. S., and Chapman, 
S. K. (1988) Probing the active site of flavocytochrome b2 by site-directed 
mutagenesis, Eur. J. Biochem. 178, 329-333. 
12. Macheroux, P., Kieweg, V., Massey, V., Soderlind, E., Stenberg, K., and 
Lindqvist, Y. (1993) Role of tyrosine 129 in the active site of spinach glycolate 
oxidase, Eur. J. Biochem. 213, 1047-1054. 
13. Rouviere-Fourmy, N., Capeillere-Blandin, C., and Lederer, F. (1994) Role of 
tyrosine 143 in lactate dehydrogenation by flavocytochrome b2. Primary kinetic 
isotope effect studies with a phenylalanine mutant, Biochemistry 33, 798-806. 
14. Müh, U., Williams, C. H., Jr., and Massey, V. (1994) Lactate monooxygenase II. 
 153 
Site-directed mutagenesis of the postulated active site base histidine 290, J. Biol. 
Chem. 269, 7989-7993. 
15. Müh, U., Williams, C. H., Jr., and Massey, V. (1994) Lactate monooxygenase 
III. Additive contributions of active site residues to catalytic efficiency and 
stabilization of an anionic transition state, J. Biol. Chem. 269, 7994-8000. 
16. Gaume, B., Sharp, R. E., Manson, F. D. C., Chapman, S. K., Reid, G. A., and 
Lederer, F. (1995) Mutation to glutamine of histidine 373, the catalytic base of 
flavocytochrome b2 (L-lactate dehydrogenase), Biochimie 77, 621-630. 
17. Lehoux, I. E., and Mitra, B. (2000) Role of arginine 277 in (S)-mandelate 
dehydrogenase from Pseudomonas putida in substrate binding and transition 
state stabilization, Biochemistry 39, 10055-10065. 
18. Lehoux, I. E., and Mitra, B. (1999) (S)-Mandelate dehydrogenase from 
Pseudomonas putida: Mutation of the catalytic base histidine-274 and chemical 
rescue of activity, Biochemistry 38, 9948-9955. 
19. Sobrado, P., and Fitzpatrick, P. F. (2003) Solvent and primary deuterium isotope 
effects show that lactate CH and OH bond cleavages are concerted in Y254F 
flavocytochrome b2, consistent with a hydride transfer mechanism, Biochemistry 
42, 15208-15214. 
20. Sanders, S. A., Williams, C. H., Jr., and Massey, V. (1999) The roles of two 
amino acid residues in the active site of L-lactate monooxygenase, J. Biol. Chem. 
274, 22289-22295.  
21. Mowat, C. G., Beaudoin, I., Durley, R. C. E., Barton, J. D., Pike, A. D., Chen, 
 154 
Z.-W., Reid, G. A., Chapman, S. K., Mathews, F. S., and Lederer, F. (2000) 
Kinetic and crystallographic studies on the active site Arg289Lys mutant of 
flavocytochrome b2 (yeast L-lactate dehydrogenase), Biochemistry 39, 3266-
3275. 
22. Lederer, F. (1996) The Mechanism of Flavoprotein-Catalyzed Alpha-hydroxy 
Acid Dehydrogenation, Revisited, in Flavins and Flavoproteins 1996 
(Stevenson, K. J., Massey, V., and Williams, C. H., Eds.) pp 545-553, University 
of Calgary Press, Alberta Canada. 
23. Fitzpatrick, P. F. (2001) Substrate dehydrogenation by flavoproteins, Acc. Chem. 
Res. 34, 299-307.  
24. Fitzpatrick, P. F. (2004) Carbanion versus hydride transfer mechanisms in 
flavoprotein-catalyzed dehydrogenations, Bioorg. Chem. 32, 125-139. 
25. Kurtz, K. A., Rishavy, M. A., Cleland, W. W., and Fitzpatrick, P. F. (2000) 
Nitrogen isotope effects as probes of the mechanism of D-amino acid oxidase, J. 
Am. Chem. Soc. 122, 12896-12897. 
26. Ralph, E. C., Anderson, M. A., Cleland, W. W., and Fitzpatrick, P. F. (2006) 
Mechanistic studies of the flavoenzyme tryptophan 2-monooxygenase: deuterium 
and 15N kinetic isotope effects on alanine oxidation by an L-amino acid oxidase, 
Biochemistry 45, 15844-15852. 
27.  Ralph, E. C., and Fitzpatrick, P. F. (2005) pH and kinetic isotope effects on 
sarcosine oxidation by N-methyltryptophan oxidase, Biochemistry 44, 3074-
3081. 
 155 
28. Dubois, J., Chapman, S. K., Mathews, F. S., Reid, G. A., and Lederer, F. (1990) 
Substitution of Tyr254 with Phe at the active site of flavocytochrome b2: 
consequences on catalysis of lactate dehydrogenation, Biochemistry 29, 6393-
6400. 
29. Sobrado, P., Daubner, S. C., and Fitzpatrick, P. F. (2001) Probing the relative 
timing of hydrogen abstraction steps in the flavocytochrome b2 reaction with 
primary and solvent deuterium isotope effects and mutant enzymes, Biochemistry 
40, 994-1001. 
30. Labeyrie, F., Baudras, A., and Lederer, F. (1978) Flavocytochrome b2 or L-
lactate cytochrome c reductase from yeast, Methods Enzymol. 53, 238-256. 
31. Iwatsubo, I., Mevel-Ninio, M., and Labeyrie, F. (1977) Rapid kinetic studies of 
partial reactions in the heme free derivative of L-lactate cytochrome c 
oxidoreductase (flavocytochrome b2); the flavodehydrogenase function, Bio-
chemistry 16, 3558-3566. 
32. McPherson, A. (1982) Preparation and Analysis of Protein Crystals, John Wiley, 
New York. 
33. Otwinowski, Z., and Minor, W. (1997) Processing of X-ray diffraction data 
collected in oscillation mode, Methods Enzymol. 276, 307-326. 
34. Matthews, B. W. (1968) Solvent content of protein crystals, J. Mol. Biol. 33, 
491-497. 
35. Kissinger, C. R., Gehlhaar, D. K., and Fogel, D. B. (1999) Rapid automated 
molecular replacement by evolutionary search, Acta Crystallogr., Sect. D 55, 
 156 
484-491. 
36. Kantardjieff, K. A., Hochtl, P., Segelke, B. W., Tao, F. M., and Rupp, B. (2002) 
Concanavalin A in a dimeric crystal form: revisiting structural accuracy and 
molecular flexibility, Acta Crystallogr., Sect. D 58, 735-743. 
37. McRee, D. E. (1999) XtalView/Xfit-A versatile program for manipulating atomic 
coordinates and electron density, J. Struct. Biol. 125, 156-165. 
38. Miles, C. S., Rouviere-Fourmy, N., Lederer, F., Mathews, F. S., Reid, G. A., 
Black, M. T., and Chapman, S. K. (1992) Tyr-143 facilitates interdomain 
electron transfer in flavocytochrome b2, Biochem. J. 285, 187-192. 
39. Cunane, L. M., Barton, J. D., Chen, Z. W., Welsh, F. E., Chapman, S. K., Reid, 
G. A., and Mathews, F. S. (2002) Crystallographic study of the recombinant 
flavin-binding domain of baker’s yeast flavocytochrome b2: comparison with the 
intact wild-type enzyme, Biochemistry 41, 4264-4272.  
40. Ghanem, M., and Gadda, G. (2005) On the catalytic role of the conserved active 
site residue His466 of choline oxidase, Biochemistry 44, 893-904. 
 157 
VITA 
 
Name: Chi-Lin Tsai 
Address: 301 Old Main Dr., ILSB Rm. 1196  
 College Station, TX 77843 
  
 Department of Chemistry 
 M.S. 3255 
 c/o Dr. David Barondeau 
 
Email Address: cltsai70@yahoo.com.tw 
 
Education: B.S., Chemistry, National Chung Hsing University, 1998 
 M.S., Chemistry, National Taiwan University, 2000 
 Ph.D., Chemistry, Texas A&M University, 2011 
 
